Item 11(f).
Selected Financial Data
(dollars in thousands, unless otherwise stated)
The following table sets forth the Company’s selected historical financial data. The selected financial data has been derived from the Statutory Financial Statements included elsewhere in this prospectus, and should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the Company’s audited Statutory Financial Statements.
These historical results are not necessarily indicative of results to be expected for any future period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
Selected income data |
| 2023 |
| 2022 |
| 2021 |
| 2020 |
| 2019 |
Premium and annuity considerations* |
| $ | 972,773 |
|
| 658,839 |
|
| 689,602 |
|
| 431,944 |
|
| 376,919 |
|
Net investment income |
| 20,031 |
|
| 18,100 |
|
| 16,177 |
|
| 18,028 |
|
| 19,866 |
|
Ceded reinsurance reserve and expense adjustments |
| 1,791 |
|
| 1,146 |
|
| 578 |
|
| 291 |
|
| 181 |
|
Fees from separate accounts |
| 54,306 |
|
| 58,894 |
|
| 66,792 |
|
| 66,045 |
|
| 68,960 |
|
| | | | | | | | | | |
Total income |
| 1,048,901 |
|
| 736,979 |
|
| 773,149 |
|
| 516,308 |
|
| 465,926 |
|
Policyholder benefits and surrenders |
| 549,361 |
|
| 274,066 |
|
| 281,533 |
|
| 244,532 |
|
| 255,885 |
|
Change in aggregate reserves |
| (32,581) |
|
| 76,056 |
|
| (17,165) |
|
| 1,842 |
|
| 2,503 |
|
General and administrative and commission |
| 108,020 |
|
| 82,936 |
|
| 78,354 |
|
| 56,875 |
|
| 52,630 |
|
Net transfers to separate accounts |
| 396,569 |
|
| 351,286 |
|
| 358,538 |
|
| 186,015 |
|
| 134,980 |
|
Total benefits and other expenses |
| 1,021,369 |
|
| 784,344 |
|
| 701,260 |
|
| 489,264 |
|
| 445,998 |
|
Income tax expense (benefit) |
| (1,665) |
|
| 3,586 |
|
| 6,319 |
|
| 1,280 |
|
| (7,343) |
|
Net realized capital (loss) gain |
| (41,157) |
|
| 22,638 |
|
| (59,957) |
|
| (41,220) |
|
| (70,095) |
|
Net (loss) income |
| (11,960) |
|
| (28,313) |
|
| 5,613 |
|
| (15,456) |
|
| (42,824) |
|
Capital and Surplus: |
|
|
|
|
|
|
|
|
|
|
Change in unrealized capital (loss) gain |
| (7,720) |
|
| 4,843 |
|
| 1,534 |
|
| (1,845) |
|
| (8,937) |
|
Other change in capital & surplus |
| 3,316 |
|
| 2,024 |
|
| (106) |
|
| 1,934 |
|
| (649) |
|
Capital contribution from parent |
| 30,000 |
|
| 30,000 |
|
| — |
|
| — |
|
| — |
|
Net change in capital & surplus |
| $ | 13,636 |
|
| 8,554 |
|
| 7,041 |
|
| (15,367) |
|
| (52,410) |
|
*Includes premiums and annuity and supplementary contract considerations. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, |
Selected balance sheet data |
| 2023 |
| 2022 |
| 2021 |
| 2020 |
| 2019 |
Total cash and invested assets |
| $ | 650,763 |
|
| 671,072 |
|
| 610,691 |
|
| 590,406 |
|
| 596,501 |
|
Investment income due and accrued |
| 5,071 |
|
| 4,719 |
|
| 4,480 |
|
| 4,744 |
|
| 4,921 |
|
Other admitted assets |
| 24,431 |
|
| 8,914 |
|
| 9,085 |
|
| 8,604 |
|
| 12,922 |
|
Separate account assets |
| 5,399,495 |
|
| 4,347,526 |
|
| 4,447,304 |
|
| 3,773,866 |
|
| 3,232,062 |
|
Total admitted assets |
| 6,079,760 |
|
| 5,032,231 |
|
| 5,071,560 |
|
| 4,377,620 |
|
| 3,846,406 |
|
Total policyholder liabilities |
| 530,368 |
|
| 550,065 |
|
| 473,598 |
|
| 490,011 |
|
| 487,107 |
|
Other liabilities |
| (35,303) |
|
| (40,924) |
|
| (12,352) |
|
| (42,226) |
|
| (44,099) |
|
Separate account liabilities |
| 5,399,495 |
|
| 4,347,526 |
|
| 4,447,304 |
|
| 3,773,866 |
|
| 3,232,062 |
|
Total liabilities |
| 5,894,560 |
|
| 4,856,667 |
|
| 4,908,550 |
|
| 4,221,651 |
|
| 3,675,070 |
|
Total capital and surplus |
| $ | 185,200 |
|
| 171,564 |
|
| 163,010 |
|
| 155,969 |
|
| 171,336 |
|
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 1 of 13
Item 11(h).
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis provides an assessment by management of the Company’s financial condition as of December 31, 2023, compared with December 31, 2022, and its results of operations for each of the three years ended December 31, 2023, 2022, 2021, respectively. The information contained herein should be read in conjunction with the financial statements, notes, exhibits and schedules in the 2023 and 2022 Annual Statement and audited Statutory Financial Statements of the Company. Amounts are presented on a non-consolidated basis in accordance with Statutory Accounting Principles (SAP).
Forward-looking Statements
This report reviews the Company’s financial condition and results of operations. Where appropriate, factors that may affect future financial performance are also identified and discussed. Certain statements made in this report include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include any statement that may predict, forecast, indicate or imply future results, performance or achievements instead of historical facts, and may contain words like “believe”, “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “plan”, “will”, “shall”, “may”, and other words, phrases or expressions with similar meaning. Forward-looking statements are subject to risks and uncertainties. Readers are cautioned not to place undue reliance on forward-looking statements as a prediction of actual results. The Company undertakes no obligation to update publicly or revise any forward-looking statements.
Company Overview
The Company is a life insurance company domiciled in New York and is licensed to sell insurance products in six U.S. states and the District of Columbia. The Company primarily offers individual variable-indexed annuities which are sold through licensed registered representatives contracted with a broker/dealer. The Company also maintains a closed portfolio of individual traditional variable annuities, fixed annuities, individual and group life policies, and individual and group accident and health policies, but does not actively issue new policies related to these products.
Allianz Life of New York is a wholly owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life). Allianz Life is a wholly owned subsidiary of Allianz of America, Inc. (AZOA), which is a subsidiary of Allianz Europe, B.V.. Allianz Europe, B.V. is a wholly owned subsidiary of Allianz SE, the Company’s ultimate parent, which is incorporated in Munich, Germany.
The Company has organized its principal operations into the following segments: Individual Annuities and Other.
Individual Annuities
The Individual Annuities segment provides tax-deferred investment growth and lifetime income opportunities for our customers through fixed, fixed-indexed, variable-indexed and variable products. The “fixed” and “variable” classifications describe whether we or the contractholders bear the investment risk of the assets supporting the contract.
Variable annuities allow the contractholder to make deposits into various investment options and also have unique product features that allow for guaranteed minimum income benefits, guaranteed minimum accumulation benefits, guaranteed minimum death benefits, and guaranteed minimum withdrawal benefits. The variable annuity products with guaranteed minimum benefits which provide a minimum return based on their initial deposit may be increased by additional deposits, bonus amounts, or other account crediting features. The income and accumulation benefits shift a portion of the investment risk from the contractholder back to the Company.
The Company's variable annuity sales strategy is focused on variable-indexed annuity products, which combines a separate account option with a general account option that is similar to a fixed-indexed annuity. Sales of our variable-indexed annuity have increased in recent years due to an industry shift from traditional variable products as well as the Allianz Index Advantage® New York Variable Annuity product being very competitive. Our Individual Annuity products are sold through independent distribution channels made up of registered representatives.
The Company discontinued selling traditional variable annuities and fixed annuities and the business is in run-off, however, in-force contracts are material and thus reported within the Individual Annuities segment.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 2 of 13
Other
The Other segment consists of individual term life, which is not material enough to break out in a separate segment, as well as closed blocks of life, long-term care (LTC), and Special Markets products. The Special Markets products include individual and group annuity and life products, including whole and term life insurance. Although Other products are part of the combined results, the Company does not allocate additional resources to these areas other than to maintain the operational support to its current customers.
Income and expense allocation
We maintain segregated investment portfolios for the Company but do not maintain segregated portfolios for each segment. All net investment income and other Corporate income and expense activity is allocated to the segments. Assets are only monitored at the total Company level, and as such, asset disclosures by segment are not included herein.
Income and expense related to assets backing policyholder reserves are allocated to the segments based on policyholder statutory reserve levels. The results of our segments also reflect allocation of income and expense related to assets backing surplus. Income and expense related to assets backing surplus are allocated to the segments based on estimated required capital levels for each segment.
Basis of Presentation
The Statutory Financial Statements have been prepared in accordance with accounting practices prescribed or permitted by the New York State Department of Financial Services (the Department). The Department recognizes statutory accounting practices prescribed or permitted by the state of New York for determining and reporting the financial condition and results of operations of an insurance company and its solvency under New York insurance law. The state of New York has adopted the National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual as its prescribed basis of statutory accounting principles (SAP). The state of New York has also adopted certain prescribed accounting practices that differ from those found in NAIC SAP. The Company has no material statutory accounting practices that differ from those of the Department or NAIC SAP. These practices differ in some respects from accounting principles generally accepted in the United States of America (U.S. GAAP). The effects of these differences, while not quantified, are presumed to be material to the Statutory Financial Statements.
The preparation of Statutory Financial Statements in conformity with NAIC SAP requires management to make certain estimates and assumptions that affect reported amounts of admitted assets and liabilities, including reporting or disclosure of contingent assets and liabilities as of December 31, 2023, and 2022 and the reported amounts of revenues and expenses during the reporting period. Future events, including changes in mortality, morbidity, interest rates, capital markets, and asset valuations could cause actual results to differ from the estimates used within the Statutory Financial Statements. Such changes in estimates are recorded in the period they are determined.
Adoption of New Financial Accounting Standards
See Note 3 – “Accounting Changes and Correction of Errors” of the Company’s audited Statutory Financial Statements in this prospectus for information related to recent accounting pronouncements.
Application of Critical Accounting Policies
Our accounting policies require management to make interpretative and valuation judgments and to make estimates based upon assumptions that affect the amounts of assets, liabilities, revenues, and expenses reported in our Statutory Financial Statements. Because the use of assumptions and estimates inherently entails uncertainty, the effects of accounting policies under different conditions could produce results that are significantly different. A discussion of the presentation of the business factors that affect critical accounting policies can be found in Note 2 of the accompanying Statutory Financial Statements and are summarized below.
Accounting for Investments
Investment valuation and presentation are determined to be in accordance with methods prescribed by the NAIC. See Note 5 and 6 of the audited Statutory Financial Statements for additional information regarding the portfolio and fair value of investments.
Aggregate Reserves for Life Policies and Annuity Contracts
See Notes 10 through 12 of the audited Statutory Financial Statements for additional information regarding our annuity and life actuarial reserves, deposit liabilities, and separate accounts.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 3 of 13
Derivatives
See Notes 2 and 5 of the audited Statutory Financial Statements for additional information regarding our derivatives and hedging instruments.
Reinsurance
See Note 9 of the audited Statutory Financial Statements for additional information regarding reinsurance agreements we have entered into to manage insurance risk as well as businesses we have exited.
Income Taxes
See Note 7 of the audited Statutory Financial Statements for additional information regarding income tax estimates and assumptions.
Individual Annuities and Other
Based upon the significance of the Individual Annuities segment and its overall impact on the total results of operations, we only provided variance commentary at the total company level for the year ended December 31, 2023 compared to 2022 and year ended December 31, 2022, compared to 2021.
Total Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| Increase (decrease) and % change |
| Increase (decrease) and % change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium and annuity considerations* | $ | 972,773 |
|
| 658,839 |
|
| 689,602 |
|
| $ | 313,934 |
|
| 47.6 | % |
| $ | (30,763) |
|
| (4.5) | % |
Net investment income | 20,031 |
|
| 18,100 |
|
| 16,177 |
|
| 1,931 |
|
| 10.7 |
|
| 1,923 |
|
| 11.9 |
|
Ceded reinsurance reserve and expense adjustments | 1,791 |
|
| 1,146 |
|
| 578 |
|
| 645 |
|
| 56.3 |
|
| 568 |
|
| 98.3 |
|
Fees from separate accounts | 54,306 |
|
| 58,894 |
|
| 66,792 |
|
| (4,588) |
|
| (7.8) |
|
| (7,898) |
|
| (11.8) |
|
| | | | | | | | | | | | | |
Total income | 1,048,901 |
|
| 736,979 |
|
| 773,149 |
|
| 311,922 |
|
| 42.3 |
|
| (36,170) |
|
| (4.7) |
|
Benefits and other expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and surrenders | 549,361 |
|
| 274,066 |
|
| 281,533 |
|
| 275,295 |
|
| 100.4 |
|
| (7,467) |
|
| (2.7) |
|
Change in aggregate reserves | (32,581) |
|
| 76,056 |
|
| (17,165) |
|
| (108,637) |
|
| (142.8) |
|
| 93,221 |
|
| 543.1 |
|
General and administrative and commission | 108,020 |
|
| 82,936 |
|
| 78,354 |
|
| 25,084 |
|
| 30.2 |
|
| 4,582 |
|
| 5.8 |
|
Net transfers to separate accounts | 396,569 |
|
| 351,286 |
|
| 358,538 |
|
| 45,283 |
|
| 12.9 |
|
| (7,252) |
|
| (2.0) |
|
Total benefits and other expenses | 1,021,369 |
|
| 784,344 |
|
| 701,260 |
|
| 237,025 |
|
| 30.2 |
|
| 83,084 |
|
| 11.8 |
|
Pretax income (loss) | 27,532 |
|
| (47,365) |
|
| 71,889 |
|
| 74,897 |
|
| 158.1 |
|
| (119,254) |
|
| (165.9) |
|
Income tax expense (benefit) | (1,665) |
|
| 3,586 |
|
| 6,319 |
|
| (5,251) |
|
| (146.4) |
|
| (2,733) |
|
| (43.3) |
|
Net realized capital (loss) gain | (41,157) |
|
| 22,638 |
|
| (59,957) |
|
| (63,795) |
|
| (281.8) |
|
| 82,595 |
|
| 137.8 |
|
Net (loss) income | $ | (11,960) |
|
| (28,313) |
|
| 5,613 |
|
| $ | 16,353 |
|
| 57.8 | % |
| $ | (33,926) |
|
| (604.4) | % |
Capital and Surplus: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized capital (loss) gain | $ | (7,720) |
|
| 4,843 |
|
| 1,534 |
|
| $ | (12,563) |
|
| (259.4) | % |
| $ | 3,309 |
|
| 215.7 | % |
Other change in capital & surplus | 3,316 |
|
| 2,024 |
|
| (106) |
|
| 1,292 |
|
| 63.8 |
|
| 2,130 |
|
| 2,009.4 |
|
Capital contribution from parent | 30,000 |
|
| 30,000 |
|
| — |
|
| — |
|
| — |
|
| 30,000 |
|
| NM^ |
Net change in capital & surplus | $ | 13,636 |
|
| 8,554 |
|
| 7,041 |
|
| $ | 5,082 |
|
| 59.4 | % |
| $ | 1,513 |
|
| 21.5 | % |
*Includes premiums and annuity and supplementary contract considerations. |
^ Not meaningful |
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 4 of 13
Selected Operating Performance Measures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| Increase (decrease) and % change |
| Increase (decrease) and % change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Deposits and gross premiums written: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual Annuities | $ | 967,460 |
|
| 653,562 |
|
| 685,610 |
|
| $ | 313,898 |
|
| 48.0 | % |
| $ | (32,048) |
|
| (4.7) | % |
Other | 6,719 |
|
| 5,492 |
|
| 4,416 |
|
| 1,227 |
|
| 22.3 |
|
| 1,076 |
|
| 24.4 |
|
Total | $ | 974,179 |
|
| 659,054 |
|
| 690,026 |
|
| $ | 315,125 |
|
| 47.8 | % |
| $ | (30,972) |
|
| (4.5) | % |
In-force: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual Annuities | $ | 5,642,883 |
|
| 4,654,719 |
|
| 4,797,886 |
|
| $ | 988,164 |
|
| 21.2 | % |
| $ | (143,167) |
|
| (3.0) | % |
Other | 2,921,758 |
|
| 1,837,298 |
|
| 750,332 |
|
| 1,084,460 |
|
| 59.0 |
|
| 1,086,966 |
|
| 144.9 |
|
Total | $ | 8,564,641 |
|
| 6,492,017 |
|
| 5,548,218 |
|
| $ | 2,072,624 |
|
| 31.9 | % |
| $ | 943,799 |
|
| 17.0 | % |
Deposits and in-force amounts in the table above are for direct business. Deposits reflect amounts collected on both new and renewal business. Individual Annuities in-force represents account values for our annuity contracts. Other products in-force represent gross life insurance within the life and Special Markets products. The deposits increased within Individual Annuities in 2023 as a result of higher variable-indexed annuity sales driven by competitve product features and the market environment. The increase of in-force in the Individual Annuities segment in 2023 is primarily driven by equity market increases resulting in higher contractholder account values. Deposits and in-force within Other products increased in 2023 due to term life policy sales.
Change in Key Market Factors
Our Individual Annuities segment is impacted by various market impacts and movements which are summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| % change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Stock Index |
|
|
|
|
|
|
|
|
|
S&P 500 | 24.23% |
| (19.44)% |
| 26.89% |
| 43.67% |
| (46.33)% |
NASDAQ 100 | 53.81% |
| (32.97)% |
| 26.63% |
| 86.78% |
| (59.60)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| Basis point (bps) change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Interest Rates |
|
|
|
|
|
|
|
|
|
Swap rate - 10 year | 3.48% |
| 3.84% |
| 1.58% |
| (36) bps |
| 226 bps |
Swap rate - 20 year | 3.51% |
| 3.74% |
| 1.76% |
| (23) bps |
| 198 bps |
Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
Overview
The change in capital and surplus was favorable in 2023 primarily due to a capital contribution from Allianz Life and decreased aggregate reserves, partially offset by net realized capital losses driven by positive equity markets.
Income
•Premium and annuity considerations: Premium and annuity considerations increased primarily due to equity market volatility which enhanced variable-indexed annuity premium in 2023.
•Net investment income: Net investment income increased primarily due to a increase in average invested assets and higher asset yields.
•Ceded reinsurance reserve and expense adjustments: Ceded reinsurance reserve and expense adjustments increased primarily due to the ceded expense allowance on term life product sales.
•Fees from separate accounts: Fees from separate accounts decreased primarily due to lower separate account assets on the traditional variable annuity block of business as these products are no longer sold.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 5 of 13
Benefits and Other Expenses
•Policyholder benefits and surrenders: Policyholder benefits and surrenders increased significantly due to an increase in variable annuity surrenders.
•Change in aggregate reserves: Change in aggregate reserves was driven by VM 21 reserve decreases due to equity market impacts and interest rate movements impacting the variable annuity line of business. Fixed annuity reserves also decreased due to the continued run-off of the closed block of business.
•General and administrative and commission: General and administrative and commission increased primarily due to an increase in commissions as a result of increased variable-indexed annuity premium.
•Net transfers to separate accounts: Net transfers to separate accounts is driven by new premium and offset by contractholder withdrawals, and decreased due to increased surrender benefits and withdrawals for variable annuity contracts.
•Income tax expense (benefit): Income tax benefit increase driven by pre-tax income and hedging impacts.
•Net realized capital gain (loss): Net realized capital losses are driven by derivatives that hedge guarantees in our Individual Annuities segment due to an increase in equity markets.
Capital and Surplus
•Change in unrealized capital gain (loss): Unrealized capital losses are primarily due to derivatives that hedge guarantees in our Individual Annuities segment due to an increase in equity markets.
•Other change in capital and surplus: Other change in capital and surplus increase was driven by a decrease in net deferred income tax primarily due to changes in Statutory versus tax reserves.
Year Ended December 31, 2022 Compared to Year Ended December 31, 2021
Overview
The change in capital and surplus was favorable in 2022 primarily due to a capital contribution from Allianz Life and net realized capital gains on derivatives due to negative equity markets, partially offset by increased aggregate reserves driven by additional asset adequacy reserves.
Income
•Premium and annuity considerations: Premium and annuity considerations decreased primarily due to equity market volatility which reduced variable-indexed annuity premium in 2022.
•Net investment income: Net investment income increased primarily due to a increase in average invested assets and higher asset yields.
•Ceded reinsurance reserve and expense adjustments: Ceded reinsurance reserve and expense adjustments increased primarily due to the ceded expense allowance on term life product sales.
•Fees from separate accounts: Fees from separate accounts decreased, primarily due to lower M&E and benefit rider income from the effects of negative equity markets in 2022, which resulted in lower average traditional variable annuity separate account assets in 2022.
Benefits and Other Expenses
•Policyholder benefits and surrenders: Policyholder benefits and surrenders decreased primarily due to a decrease in variable annuity surrenders.
•Change in aggregate reserves: Change in aggregate reserves was driven by additional asset adequacy reserves on both the variable annuity and fixed annuity lines of business and VM 21 reserve increases due to equity market impacts and interest rate movements impacting the variable annuity line of business. This was partially offset by fixed annuity reserve decreases due to the continued run-off of the closed block of business.
•General and administrative and commission: General and administrative and commission increased primarily due to an increase in sundry general expenses.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 6 of 13
•Net transfers to separate accounts: Net transfers to separate accounts decrease is driven by new premium and policyholder withdrawals, and decreased due to lower variable-indexed premium.
•Income tax expense (benefit): Income tax expense decreased driven by pre-tax income and hedging impacts.
•Net realized capital (loss) gain: Net realized capital gains are driven by derivatives that hedge guarantees in our Individual Annuities segment due to a decrease in equity markets.
Capital and Surplus
•Change in unrealized capital gain (loss): Unrealized capital gains are primarily due to derivatives that hedge guarantees in our Individual Annuities segment due to a decrease in equity markets.
•Other change in capital and surplus: Other change in capital and surplus decrease was driven by an increase in net deferred income tax primarily due to changes in Statutory versus tax reserves.
The following tables provide the results of operations for the Individual Annuities and Other segments:
Individual Annuities
Segment Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| Increase (decrease) and % change |
| Increase (decrease) and % change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium and annuity considerations* | $ | 969,768 |
|
| 655,804 |
|
| 686,652 |
|
| $ | 313,964 |
|
| 47.9 | % |
| $ | (30,848) |
|
| (4.5) | % |
Net investment income | 15,527 |
|
| 13,899 |
|
| 12,181 |
|
| 1,628 |
|
| 11.7 |
|
| 1,718 |
|
| 14.1 |
|
Fees from separate accounts | 54,306 |
|
| 58,894 |
|
| 66,792 |
|
| (4,588) |
|
| (7.8) |
|
| (7,898) |
|
| (11.8) |
|
| | | | | | | | | | | | | |
Total income | 1,039,601 |
|
| 728,597 |
|
| 765,625 |
|
| 311,004 |
|
| 42.7 |
|
| (37,028) |
|
| (4.8) |
|
Benefits and other expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and surrenders | 546,381 |
|
| 271,102 |
|
| 279,788 |
|
| 275,279 |
|
| 101.5 |
|
| (8,686) |
|
| (3.1) |
|
Change in aggregate reserves | $ | (35,645) |
|
| 71,289 |
|
| (25,127) |
|
| $ | (106,934) |
|
| (150.0) | % |
| $ | 96,416 |
|
| 383.7 | % |
General and administrative and commission | 104,727 |
|
| 79,959 |
|
| 76,484 |
|
| 24,768 |
|
| 31.0 |
|
| 3,475 |
|
| 4.5 |
|
Net transfers to separate accounts | 396,569 |
|
| 351,286 |
|
| 358,538 |
|
| 45,283 |
|
| 12.9 |
|
| (7,252) |
|
| (2.0) |
|
Total benefits and other expenses | 1,012,032 |
|
| 773,636 |
|
| 689,683 |
|
| 238,396 |
|
| 30.8 |
|
| 83,953 |
|
| 12.2 |
|
Pretax income (loss) | 27,569 |
|
| (45,039) |
|
| 75,942 |
|
| 72,608 |
|
| 161.2 |
|
| (120,981) |
|
| (159.3) |
|
Income tax expense (benefit) | (1,668) |
|
| 3,409 |
|
| 6,675 |
|
| (5,077) |
|
| (148.9) | % |
| (3,266) |
|
| (48.9) | % |
Net realized capital (loss) gain | (41,149) |
|
| 22,688 |
|
| (59,965) |
|
| (63,837) |
|
| (281.4) |
|
| 82,653 |
|
| 137.8 |
|
Net income (loss) | $ | (11,912) |
|
| (25,760) |
|
| 9,302 |
|
| $ | 13,848 |
|
| 53.8 | % |
| $ | (35,062) |
|
| (376.9) | % |
Capital and Surplus: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized capital (loss) gain | $ | (7,946) |
|
| 4,997 |
|
| 1,627 |
|
| $ | (12,943) |
|
| (259.0) | % |
| $ | 3,370 |
|
| 207.1 | % |
Other change in capital & surplus | 2,870 |
|
| 1,756 |
|
| (88) |
|
| 1,114 |
|
| 63.4 |
|
| 1,844 |
|
| 2,095.5 |
|
Net change in capital & surplus | $ | (16,988) |
|
| $ | (19,007) |
|
| $ | 10,841 |
|
| $ | 2,019 |
|
| 10.6 | % |
| $ | (29,848) |
|
| (275.3) | % |
*Includes premiums and annuity and supplementary contract considerations. |
^Not meaningful |
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 7 of 13
Other
Segment Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| Increase (decrease) and % change |
| Increase (decrease) and % change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium and annuity considerations | $ | 3,005 |
|
| 3,035 |
|
| 2,950 |
|
| $ | (30) |
|
| (1.0) | % |
| $ | 85 |
|
| 2.9 | % |
Net investment income | 4,504 |
|
| 4,201 |
|
| 3,996 |
|
| 303 |
|
| 7.2 |
|
| 205 |
|
| 5.1 |
|
Ceded reinsurance reserve and expense adjustments | 1,791 |
|
| 1,146 |
|
| 578 |
|
| 645 |
|
| 56.3 |
|
| 568 |
|
| 98.3 |
|
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Total income | 9,300 |
|
| 8,382 |
|
| 7,524 |
|
| 918 |
|
| 11.0 |
|
| 858 |
|
| 11.4 |
|
Benefits and other expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and surrenders | 2,980 |
|
| 2,964 |
|
| 1,745 |
|
| 16 |
|
| 0.5 |
|
| 1,219 |
|
| 69.9 |
|
Change in aggregate reserves | 3,064 |
|
| 4,767 |
|
| 7,962 |
|
| (1,703) |
|
| (35.7) |
|
| (3,195) |
|
| (40.1) |
|
General and administrative and commission | 3,293 |
|
| 2,977 |
|
| 1,870 |
|
| 316 |
|
| 10.6 |
|
| 1,107 |
|
| 59.2 |
|
| | | | | | | | | | | | | |
Total benefits and other expenses | 9,337 |
|
| 10,708 |
|
| 11,577 |
|
| (1,371) |
|
| (12.8) |
|
| (869) |
|
| (7.5) |
|
Pretax (loss) income | (37) |
|
| (2,326) |
|
| (4,053) |
|
| 2,289 |
|
| 98.4 |
|
| 1,727 |
|
| 42.6 |
|
Income tax expense (benefit) | 2 |
|
| 176 |
|
| (356) |
|
| (174) |
|
| (98.9) |
|
| 532 |
|
| 149.4 |
|
Net realized capital (loss) gain | (8) |
|
| (50) |
|
| 8 |
|
| 42 |
|
| 84.0 |
|
| (58) |
|
| (725.0) |
|
Net income (loss) | $ | (47) |
|
| (2,552) |
|
| (3,689) |
|
| $ | 2,505 |
|
| 98.2 | % |
| $ | 1,137 |
|
| 30.8 | % |
Capital and Surplus: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized capital gain (loss) | $ | 226 |
|
| (154) |
|
| (93) |
|
| $ | 380 |
|
| 246.8 | % |
| $ | (61) |
|
| (65.6) | % |
Other change in capital & surplus | 446 |
|
| 268 |
|
| (18) |
|
| 178 |
|
| 66.4 | % |
| 286 |
|
| 1,588.9 |
|
Net change in capital & surplus | $ | 625 |
|
| (2,438) |
|
| (3,800) |
|
| $ | 3,063 |
|
| 125.6 |
|
| $ | 1,362 |
|
| 35.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Contributions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
| Increase (decrease) and % change |
| 2023 |
| 2022 |
| 2021 |
| 2023 - 2022 |
| 2022 - 2021 |
Capital and Surplus: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Contribution from parent | $ | 30,000 |
|
| 30,000 |
|
| — |
|
| $ | — |
|
| — | % |
| $ | 30,000 |
|
| NM* |
*Not meaningful |
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital contributions were received from Allianz Life as shown above. See Note 13 of the Company’s audited Statutory Financial Statements for further reference.
Financial Condition
Investment Strategy
Our investment strategy focuses on diversification by asset class. We seek to achieve economic diversification, while limiting overall credit and liquidity risks. We attempt to mitigate these credit and liquidity risks by adhering to investment policies that provide portfolio diversification on an asset class, creditor, and industry basis, and by complying with investment limitations governed by state insurance laws and regulations, as applicable. We also consider all relevant objective information available in estimating the cash flows related to structured securities. We actively monitor and manage exposures, and determine whether any securities are impaired. The aggregate credit risk taken in the investment portfolio is influenced by our risk/return preferences, the economic and credit environment, and the ability to manage this risk through liability portfolio management. We also have an asset-liability management strategy to align cash flows and duration of the investment portfolio with contractholder liability cash flows and duration.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 8 of 13
The following table presents the investment portfolio at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| Carrying Value |
| % of total |
| Carrying Value |
| % of total |
Bonds | $ | 618,672 |
|
| 95.1 | % |
| $ | 647,422 |
|
| 96.5 | % |
Cash and cash equivalents | 31,012 |
|
| 4.8 |
|
| 22,009 |
|
| 3.3 |
|
Policy loans | 193 |
|
| — |
|
| 185 |
|
| — |
|
Derivative assets | 26 |
|
| — |
|
| — |
|
| — |
|
Receivables for securities | 860 |
|
| 0.1 |
|
| 1,456 |
|
| 0.2 |
|
Total cash and invested assets | $ | 650,763 |
|
| 100.0 | % |
| $ | 671,072 |
|
| 100.0 | % |
Bonds
Refer to Note 5 of the audited Statutory Financial Statements for information regarding the nature of our portfolio of bonds. The tables below represents the NAIC ratings for the Company's bond portfolio at December 31, 2023 and 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
NAIC Classes | Fair Value |
| % of Total |
| Amortized Cost |
| % of Total |
1 | $ | 390,284 |
|
| 67.2 | % |
| $ | 419,486 |
|
| 67.8 | % |
2 | 184,922 |
|
| 31.9 |
|
| 194,060 |
|
| 31.4 |
|
Investment grade | 575,206 |
|
| 99.1 |
|
| 613,546 |
|
| 99.2 |
|
3 | 5,082 |
|
| 0.9 |
|
| 5,126 |
|
| 0.8 |
|
4 | — |
|
| — |
|
| — |
|
| — |
|
5 | — |
|
| — |
|
| — |
|
| — |
|
6 | — |
|
| — |
|
| — |
|
| — |
|
Below investment grade | 5,082 |
|
| 0.9 |
|
| 5,126 |
|
| 0.8 |
|
Total | $ | 580,288 |
|
| 100.0 | % |
| $ | 618,672 |
|
| 100.0 | % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
NAIC Classes | Fair Value |
| % of Total |
| Amortized Cost |
| % of Total |
1 | $ | 402,120 |
|
| 68.3 | % |
| $ | 442,762 |
|
| 68.4 | % |
2 | 180,165 |
|
| 30.6 |
|
| 198,397 |
|
| 30.6 |
|
Investment grade | 582,285 |
|
| 98.9 |
|
| 641,159 |
|
| 99.0 |
|
3 | 6,242 |
|
| 1.1 |
|
| 6,263 |
|
| 1.0 |
|
4 | — |
|
| — |
|
| — |
|
| — |
|
5 | — |
|
| — |
|
| — |
|
| — |
|
6 | — |
|
| — |
|
| — |
|
| — |
|
Below investment grade | 6,242 |
|
| 1.1 |
|
| 6,263 |
|
| 1.0 |
|
Total | $ | 588,527 |
|
| 100.0 | % |
| $ | 647,422 |
|
| 100.0 | % |
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 9 of 13
Commercial Mortgage-backed and Asset-backed Securities
Commercial mortgage-backed securities (CMBS) represent pools of commercial mortgages that are broadly diversified across property types and geographical areas. The following table summarizes our exposure to CMBS holdings by NAIC classes and vintage year as of December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
NAIC Classes | Amortized Cost |
| % of Total |
| Vintage | Amortized Cost |
| % of Total |
1 | $ | 72,012 |
|
| 100.0 | % |
| 2023 | $ | 1,543 |
|
| 2.1 | % |
2 | — |
|
| — |
|
| 2022 | 1,709 |
|
| 2.4 |
|
3 | — |
|
| — |
| 1 |
| 2021 | — |
|
| — |
|
4 | — |
|
| — |
|
| 2020 | 2,450 |
|
| 3.4 |
|
5 | — |
|
| — |
|
| 2019 and prior | 66,310 |
|
| 92.1 |
|
6 | — |
|
| — |
|
|
| $ | 72,012 |
|
| 100.0 | % |
| $ | 72,012 |
|
| 100.0 | % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
NAIC Classes | Amortized Cost |
| % of Total |
| Vintage | Amortized Cost |
| % of Total |
1 | $ | 74,182 |
|
| 100.0 | % |
| 2022 | $ | — |
|
| — | % |
2 | — |
|
| — |
|
| 2021 | — |
|
| — |
|
3 | — |
|
| — |
|
| 2020 | 2,457 |
|
| 3.3 |
|
4 | — |
|
| — |
|
| 2019 | 3,718 |
|
| 5.0 |
|
5 | — |
|
| — |
|
| 2018 and prior | 68,007 |
|
| 91.7 |
|
6 | — |
|
| — |
|
|
| $ | 74,182 |
|
| 100.0 | % |
| $ | 74,182 |
|
| 100.0 | % |
|
|
|
|
|
Asset backed security (ABS) holdings consist primarily of aircraft leases, credit card receivables and other asset-backed securities that meet specific criteria, such as credit quality, insurance requirements, or limits on these types of investments.
The following table summarizes our exposure to other ABS holdings by NAIC classes and vintage year as of December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
NAIC Classes | Amortized Cost |
| % of Total |
| Vintage | Amortized Cost |
| % of Total |
1 | $ | 2,800 |
|
| 100.0 | % |
| 2023 | $ | — |
|
| — | % |
2 | — |
|
| — |
|
| 2022 | — |
|
| — |
|
3 | — |
|
| — |
|
| 2021 | 2,800 |
|
| 100.0 |
|
4 | — |
|
| — |
|
| 2020 | — |
|
| — |
|
5 | — |
|
| — |
|
| 2019 and prior | — |
|
| — |
|
6 | — |
|
| — |
|
|
| $ | 2,800 |
|
| 100.0 | % |
| $ | 2,800 |
|
| 100.0 | % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
NAIC Classes | Amortized Cost |
| % of Total |
| Vintage | Amortized Cost |
| % of Total |
1 | $ | 2,825 |
|
| 100.0 | % |
| 2022 | $ | — |
|
| — | % |
2 | — |
|
| — |
|
| 2021 | 2,800 |
|
| 99.1 |
|
3 | — |
|
| — |
|
| 2020 | — |
|
| — |
|
4 | — |
|
| — |
|
| 2019 | — |
|
| — |
|
5 | — |
|
| — |
|
| 2018 and prior | 25 |
|
| 0.9 |
|
6 | — |
|
| — |
|
|
| $ | 2,825 |
|
| 100.0 | % |
| $ | 2,825 |
|
| 100.0 | % |
|
|
|
|
|
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 10 of 13
Unrealized investment losses on bonds, for investment grade (NAIC classes 1-2) and below investment grade (NAIC classes 3-6) securities by duration are as follows at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| Investment Grade |
| % of Total |
| Below Investment Grade |
| % of Total |
Twelve months or less below fair value | $ | 419 |
|
| 0.9 | % |
| $ | — |
|
| — | % |
More than twelve months below fair value | 44,253 |
|
| 98.6 |
|
| 203 |
|
| 0.5 |
|
Total | $ | 44,672 |
|
| 99.5 | % |
| $ | 203 |
|
| 0.5 | % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
| Investment Grade |
| % of Total |
| Below Investment Grade |
| % of Total |
Twelve months or less below fair value | $ | 36,020 |
|
| 58.7 | % |
| $ | 115 |
|
| 0.2 | % |
More than twelve months below fair value | 25,225 |
|
| 41.1 |
|
| 43 |
|
| — |
|
Total | $ | 61,245 |
|
| 99.8 | % |
| $ | 158 |
|
| 0.2 | % |
See Note 5 of the audited Statutory Financial Statements for additional disclosures in regards to unrealized investment losses on bonds.
Other-than-temporary impairments, by market sector, for impairments included in the Statements of Operations, were as follows at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| Impairment |
| No. of Securities |
| Impairment |
| No. of Securities |
Corporate securities | $ | 256 |
|
| 1 |
|
| $ | 539 |
|
| 3 |
|
Refer to Note 6 of the audited Statutory Financial Statements for information regarding the fair value and fair value hierarchy level of our financial instruments.
Liquidity and Capital Resources
Overview
The Company’s liquidity requirements are generally met through funds provided by investment income, receipt of insurance premiums, M&E fees and benefit rider income, and maturities and sales of investments.
The Company does not utilize the capital markets as a source of capital. Should the need for capital arise, the Company may utilize its parent, Allianz Life, as an alternative source of funding. The Company has a line of credit agreement with its parent, Allianz Life, to provide liquidity to the Company, as needed. The Company’s borrowing capacity under the agreement is limited to 5% of the general account admitted assets of the Company as of the preceding year end which amounts to $148,028. The Company's general account admitted assets include the book value portion of the non-insulated separate account assets. As of December 31, 2023 and 2022, there are no amounts outstanding under the line of credit agreement. In addition, if capital infusions are deemed necessary, the Company obtains prior approval by the Department, as appropriate.
The primary uses of funds are policy benefits, commissions, other product-related acquisition costs, investment purchases, and operating expenses. The Company routinely reviews its sources and uses of funds in order to meet its ongoing obligations.
Financial Ratings and Strength
We received the following financial strength ratings as of December 31, 2023:
•AM Best A+ (Superior)
•S&P AA (Very Strong)
The financial strength ratings are influenced by many factors including the operating and financial performance, asset quality, liquidity, asset/liability management, overall portfolio mix, financial leverage, and exposure to risks.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 11 of 13
Cash Flows
The cash flows of the Company for the years ended December 31, 2023, 2022, and 2021 are summarized in the condensed table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended December 31, |
|
| 2023 |
| 2022 |
| 2021 |
Net cash (used in) provided by operating activities |
| $ | (7,640) |
|
| 949 |
|
| 79,047 |
|
Net cash used in investing activities |
| (23,713) |
|
| (39,612) |
|
| (67,319) |
|
Net cash provided by financing and miscellaneous activities |
| 40,355 |
|
| 31,625 |
|
| 682 |
|
Net increase (decrease) in cash and cash equivalents |
| $ | 9,002 |
|
| (7,038) |
|
| 12,410 |
|
We have the funds necessary to meet capital requirements in the state of New York and to support our operations.
The increase in net cash used in operating activities in 2023 compared to 2022 is primarily due to an increase in surrenders and annuity benefits, net transfers to separate accounts and commissions. This was partially offset by an increase in premiums and annuity considerations. The decrease in net cash provided by operating activities in 2022 compared to 2021 is primarily due to a decrease in premiums and other income, and increases in net transfers to separate accounts and commissions. This was partially offset by a decrease in surrenders and annuity benefits.
The decrease in cash flow used in investing activities in 2023 compared to 2022 was primarily driven by derivative cash impacts and a net decrease in bond purchases. The decrease in cash flow used in investing activities in 2022 compared to 2021 was primarily driven by derivative cash impacts and a net increase in bond purchases.
The increase in cash provided by financing activities in 2023 compared to 2022 is primarily due to an increase in unallocated remittances, and also remains elevated in 2023 due to a capital contribution from parent. The increase in cash provided by financing activities in 2022 compared to 2021 is primarily due to the capital contribution from parent and an increase in cash provided by other miscellaneous activities.
Risk-Based Capital
See Note 15 of the audited Statutory Financial Statements for information regarding the Risk-Based Capital (RBC). The Company's RBC ratio significantly exceeds required minimum thresholds as of December 31, 2023 and 2022.
Statutory Surplus and Dividends
The Company is required to meet minimum statutory capital and surplus requirements. The Company’s statutory capital and surplus as of December 31, 2023 and 2022 were in compliance with these requirements. The maximum amount of dividends that can be paid by New York insurance companies to stockholders without prior approval of the Department is subject to restrictions relating to statutory earned surplus, also known as unassigned funds. Unassigned funds are determined in accordance with the accounting procedures and practices governing preparation of the statutory annual statement. In accordance with New York statutes, the Company may declare and pay from its Unassigned surplus cash dividends of not more than the greater of 10% of its beginning-of-the year statutory surplus, or its net gain from operations of the insurer, not including realized gains, for the 12-month period ending the 31st day of the preceding year. Based on these restrictions, ordinary dividends of $18,520 can be paid in 2024 without the approval of the Department. The Company paid no dividends in 2023, 2022 or 2021.
Commitments & Contingencies
See Note 18 of the audited Statutory Financial Statements for information regarding commitments and contingencies
The Company has contractual obligations in the form of Policyholder liabilities, see Notes 10 through 12 of the audited Statutory Financial Statements for additional information regarding our annuity and life actuarial reserves, deposit liabilities, and separate accounts.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet transactions, arrangements or other relationships that management believes would be reasonably likely to have a material effect on the Company’s liquidity or capital position.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 12 of 13
The Company utilizes derivatives for which the company is either required to settle variation margin or post collateral; see Note 5 of the audited Statutory Financial Statements for additional information regarding derivative collateral management.
Item 11(j).
Quantitative and Qualitative Disclosures about Market Risk
Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates and equity prices. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. Reference Note 4 of the audited Statutory Financial Statements for additional details on how we mitigate our market exposure risk and our overall risk management practices.
Sensitivity Analysis
To assess the impact of changes in interest rate and equity markets, we perform sensitivity tests. Sensitivity tests measure the instantaneous impact of a single hypothetical interest rate or equity price change on our post-tax income, or fair value of an asset or liability, while holding all other rates or prices constant. To assess interest rate risk, we perform a sensitivity test which instantaneously shocks interest rates across all maturities by a hypothetical 50 basis points (bps). To assess equity risk, we perform a sensitivity test which instantaneously shocks all equity prices by a hypothetical 15%.
Interest Rate Risk
One means of assessing exposure to interest rate changes is to measure the potential change in the statutory value of an asset due to a hypothetical change in interest rates of 50 bps across all maturities. We noted that under this model, with all other factors remaining constant, a 50 bps increase in interest rates would cause our post-tax income to increase by $3,403 as of December 31, 2023.
We also examined the impact on after tax income due to a hypothetical decrease in interest rates of 50 bps across all maturities. Under this model, with all other factors being constant, we estimated that such a decline would cause our post-tax income to decrease by $4,221 as of December 31, 2023. Note that the impacts referenced reflect the net hedge impact and do not include any economic impact related to our fixed-income investment portfolio or economic changes in reserve calculations.
Equity Market Risk
One means of assessing exposure to changes in equity market prices is to estimate the potential changes in post-tax income from a hypothetical change in equity market prices of 15%. Under this model, with all other factors constant, we estimated that a decrease in equity market prices would cause our post-tax income to increase by $3,773, while an increase in equity market prices would cause our post-tax income to decrease by $12,893 based on our equity exposure as of December 31, 2023. Note that the impacts referenced reflect the net hedge impact and do not include any economic impact related to our fixed-income investment portfolio or economic changes in reserve calculations.
Management's Discussion and Analysis of Financial Condition and Results of Operations (for the 12 month period ended December 31, 2023)
Page 13 of 13
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Financial Statements
December 31, 2023 and 2022
(With Report of Independent Auditors Thereon)
Statutory Financial Statements for the year ended December 31, 2023
Report of Independent Auditors
To the Board of Directors of Allianz Life Insurance Company of New York
Opinions
We have audited the accompanying statutory financial statements of Allianz Life Insurance Company of New York (the "Company"), which comprise the statutory statements of admitted assets, liabilities and capital and surplus as of December 31, 2023 and 2022, and the related statutory statements of operations, of capital and surplus, and of cash flow for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the "financial statements").
Unmodified Opinion on Statutory Basis of Accounting
In our opinion, the accompanying financial statements present fairly, in all material respects, the admitted assets, liabilities and capital and surplus of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in accordance with the accounting practices prescribed or permitted by the New York State Department of Financial Services described in Note 2.
Adverse Opinion on U.S. Generally Accepted Accounting Principles
In our opinion, because of the significance of the matter discussed in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the accompanying financial statements do not present fairly, in accordance with accounting principles generally accepted in the United States of America, the financial position of the Company as of December 31, 2023 and 2022, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2023.
Basis for Opinions
We conducted our audit in accordance with auditing standards generally accepted in the United States of America (US GAAS). Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles
As described in Note 2 to the financial statements, the financial statements are prepared by the Company on the basis of the accounting practices prescribed or permitted by the New York State Department of Financial Services, which is a basis of accounting other than accounting principles generally accepted in the United States of America.
The effects on the financial statements of the variances between the statutory basis of accounting described in Note 2 and accounting principles generally accepted in the United States of America, although not reasonably determinable, are presumed to be material.
Responsibilities of Management for the Financial Statements
Management is responsible for the preparation and fair presentation of the financial statements in accordance with the accounting practices prescribed or permitted by the New York State Department of Financial Services. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the financial statements are available to be issued.
Statutory Financial Statements for the year ended December 31, 2023
Auditors' Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with US GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.
In performing an audit in accordance with US GAAS, we:
•Exercise professional judgment and maintain professional skepticism throughout the audit.
•Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
•Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.
•Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.
•Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.
/s/PricewaterhouseCoopers LLP
Minneapolis, Minnesota
April 8, 2024
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus
December 31, 2023 and 2022
(Dollars in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Admitted Assets |
| 2023 |
| 2022 |
Cash and invested assets: |
|
|
|
|
Bonds |
| $ | 618,672 |
|
| 647,422 |
|
Cash and cash equivalents |
| 31,012 |
|
| 22,009 |
|
Policy loans |
| 193 |
|
| 185 |
|
Derivative assets |
| 26 |
|
| — |
|
Receivables for securities |
| 860 |
|
| 1,456 |
|
Total cash and invested assets |
| 650,763 |
|
| 671,072 |
|
Investment income due and accrued |
| 5,071 |
|
| 4,719 |
|
| | | | |
| | | | |
| | | | |
| | | | |
Deferred tax asset, net |
| 10,221 |
|
| 8,439 |
|
Current federal and foreign income tax recoverable |
| 2,157 |
|
| — |
|
Admitted disallowed interest maintenance reserve |
| 11,618 |
|
| — |
|
Other assets |
| 435 |
|
| 475 |
|
Admitted assets, exclusive of separate account assets |
| 680,265 |
|
| 684,705 |
|
Separate account assets |
| 5,399,495 |
|
| 4,347,526 |
|
Total admitted assets |
| $ | 6,079,760 |
|
| 5,032,231 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus
December 31, 2023 and 2022
(Dollars in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Capital and Surplus | 2023 |
| 2022 |
Policyholder liabilities: |
|
|
|
|
Life policies and annuity contracts |
| $ | 423,911 |
|
| 459,725 |
|
Accident and health policies |
| 86,028 |
|
| 83,151 |
|
Deposit-type contracts |
| 6,478 |
|
| 6,735 |
|
Life policy and contract claims |
| 14 |
|
| 21 |
|
Accident and health policy and contract claims |
| 369 |
|
| 433 |
|
Other policyholder funds |
| 13,568 |
|
| 4,000 |
|
Total policyholder liabilities |
| 530,368 |
|
| 554,065 |
|
General expenses due and accrued |
| 2,610 |
|
| 1,108 |
|
Due from separate accounts |
| (65,902) |
|
| (64,853) |
|
Payable to parent and affiliates |
| 7,052 |
|
| 5,176 |
|
Current income taxes |
| — |
|
| 3,548 |
|
Asset valuation reserve |
| 19,896 |
|
| 12,862 |
|
| | | | |
Other liabilities |
| 1,041 |
|
| 1,235 |
|
Liabilities, exclusive of separate account liabilities |
| 495,065 |
|
| 513,141 |
|
Separate account liabilities |
| 5,399,495 |
|
| 4,347,526 |
|
Total liabilities |
| 5,894,560 |
|
| 4,860,667 |
|
Capital and surplus: |
|
|
|
|
Common stock, $10 par value. Authorized, issued, and outstanding 200,000 shares at December 31, 2023 and 2022 |
| 2,000 |
|
| 2,000 |
|
Additional paid-in capital |
| 132,500 |
|
| 102,500 |
|
Special surplus funds - admitted disallowed interest maintenance reserve |
| 11,618 |
|
| — |
|
Unassigned surplus |
| 39,082 |
|
| 67,064 |
|
Total capital and surplus |
| 185,200 |
|
| 171,564 |
|
Total liabilities and capital and surplus |
| $ | 6,079,760 |
|
| 5,032,231 |
|
|
|
|
|
|
See accompanying notes to statutory financial statements. |
|
|
|
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Operations
Years ended December 31, 2023, 2022, and 2021
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Income: |
|
|
|
|
|
|
Premiums and annuity considerations |
| $ | 970,465 |
|
| 656,597 |
|
| 688,560 |
|
Consideration for supplementary contracts |
| 2,308 |
|
| 2,242 |
|
| 1,042 |
|
Net investment income |
| 20,031 |
|
| 18,100 |
|
| 16,177 |
|
Commissions and expense allowances on reinsurance ceded |
| 1,791 |
|
| 1,146 |
|
| 578 |
|
Fees from separate accounts |
| 54,306 |
|
| 58,894 |
|
| 66,792 |
|
| | | | | | |
Total income |
| 1,048,901 |
|
| 736,979 |
|
| 773,149 |
|
Benefits and other expenses: |
|
|
|
|
|
|
Policyholder benefits |
| 57,890 |
|
| 43,865 |
|
| 40,707 |
|
Surrenders |
| 491,471 |
|
| 230,201 |
|
| 240,826 |
|
Change in aggregate reserves and deposit funds |
| (32,581) |
|
| 76,056 |
|
| (17,165) |
|
Commissions and other agent compensation |
| 62,988 |
|
| 46,104 |
|
| 47,602 |
|
General and administrative expenses |
| 45,032 |
|
| 36,832 |
|
| 30,752 |
|
Net transfers to separate accounts |
| 396,569 |
|
| 351,286 |
|
| 358,538 |
|
Total benefits and other expenses |
| 1,021,369 |
|
| 784,344 |
|
| 701,260 |
|
Income from operations before income taxes and net realized capital gain |
| 27,532 |
|
| (47,365) |
|
| 71,889 |
|
Income tax (benefit) expense |
| (1,665) |
|
| 3,586 |
|
| 6,319 |
|
Net income (loss) from operations before net realized capital gain |
| 29,197 |
|
| (50,951) |
|
| 65,570 |
|
Net realized capital (loss) gain, net of taxes and interest maintenance reserve |
| (41,157) |
|
| 22,638 |
|
| (59,957) |
|
Net (loss) income |
| $ | (11,960) |
|
| (28,313) |
|
| 5,613 |
|
|
|
|
|
|
|
|
See accompanying notes to statutory financial statements. |
|
|
|
|
|
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Capital and Surplus
Years ended December 31, 2023, 2022, and 2021
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Capital and surplus at beginning of year |
| $ | 171,564 |
|
| 163,010 |
|
| 155,969 |
|
| | | | | | |
Correction of errors, net of tax (Note 3) |
| (2,198) |
|
| — |
|
| — |
|
Adjusted balance at beginning of year |
| 169,366 |
|
| 163,010 |
|
| 155,969 |
|
Net (loss) income |
| (11,960) |
|
| (28,313) |
|
| 5,613 |
|
Change in unrealized capital gain (loss) |
| (7,720) |
|
| 4,843 |
|
| 1,534 |
|
Change in net deferred income tax |
| 880 |
|
| 8,856 |
|
| 3,807 |
|
Change in nonadmitted assets |
| (42) |
|
| (4,124) |
|
| (1,308) |
|
Capital contribution from parent |
| 30,000 |
|
| 30,000 |
|
| — |
|
Other changes in capital and surplus |
| (6,942) |
|
| (2,708) |
|
| (2,605) |
|
Change in admitted disallowed IMR |
| 11,618 |
|
| — |
|
| — |
|
Capital and surplus at end of year |
| $ | 185,200 |
|
| 171,564 |
|
| 163,010 |
|
|
|
|
|
|
|
|
See accompanying notes to statutory financial statements. |
|
|
|
|
|
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Cash Flow
Years ended December 31, 2023, 2022, and 2021
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Cash flows from operating activities: |
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
|
Premiums and annuity considerations, net |
| $ | 801,076 |
|
| 658,838 |
|
| 689,603 |
|
Net investment income |
| 22,280 |
|
| 20,141 |
|
| 19,340 |
|
Other income |
| 56,100 |
|
| 60,035 |
|
| 67,367 |
|
Total cash provided by operating activities |
| 879,456 |
|
| 739,014 |
|
| 776,310 |
|
Benefits and expenses paid: |
|
|
|
|
|
|
Benefit and loss-related payments |
| 377,129 |
|
| 272,409 |
|
| 279,458 |
|
Commissions, expenses paid, and aggregate write-ins for deductions |
| 106,560 |
|
| 82,323 |
|
| 78,441 |
|
Net transfers to separate accounts |
| 399,816 |
|
| 377,329 |
|
| 337,054 |
|
Income tax paid, net |
| 3,590 |
|
| 6,004 |
|
| 2,310 |
|
Total cash used in operating activities |
| 887,095 |
|
| 738,065 |
|
| 697,263 |
|
Net cash (used in) provided by operating activities |
| (7,639) |
|
| 949 |
|
| 79,047 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
Proceeds from investments sold, matured, or repaid: |
|
|
|
|
|
|
Bonds |
| 89,218 |
|
| 97,922 |
|
| 82,882 |
|
| | | | | | |
Derivatives |
| — |
|
| 29,969 |
|
| — |
|
Miscellaneous proceeds |
| 596 |
|
| — |
|
| 36 |
|
Total cash provided by investing activities |
| 89,814 |
|
| 127,891 |
|
| 82,918 |
|
Cost of investments acquired: |
|
|
|
|
|
|
Bonds |
| 62,148 |
|
| 166,219 |
|
| 91,367 |
|
| | | | | | |
Derivatives |
| 51,189 |
|
| — |
|
| 58,296 |
|
Miscellaneous applications |
| 190 |
|
| 1,284 |
|
| 574 |
|
Total cash used in investing activities |
| 113,527 |
|
| 167,503 |
|
| 150,237 |
|
Net cash used in investing activities |
| (23,713) |
|
| (39,612) |
|
| (67,319) |
|
Cash flows from financing and miscellaneous activities: |
|
|
|
|
|
|
Capital Contribution |
| 30,000 |
|
| 30,000 |
|
| — |
|
Change in payable to parent and affiliates |
| 1,876 |
|
| 383 |
|
| 891 |
|
Other |
| 8,479 |
|
| 1,242 |
|
| (209) |
|
Net cash provided by financing and miscellaneous activities |
| 40,355 |
|
| 31,625 |
|
| 682 |
|
Net increase (decrease) in cash and cash equivalents |
| 9,003 |
|
| (7,038) |
|
| 12,410 |
|
Cash and cash equivalents: |
|
|
|
|
|
|
Beginning of year |
| 22,009 |
|
| 29,047 |
|
| 16,637 |
|
End of year |
| $ | 31,012 |
|
| 22,009 |
|
| 29,047 |
|
|
|
|
|
|
|
|
See accompanying notes to statutory financial statements. |
|
|
|
|
|
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(1)Organization and Nature of Operations
Allianz Life Insurance Company of New York (the Company) is a wholly-owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life), which is a wholly-owned subsidiary of Allianz of America, Inc. (AZOA). AZOA is a wholly-owned subsidiary of Allianz Europe, B.V., which is a wholly-owned subsidiary of Allianz SE. Allianz SE is a European company registered in Munich, Germany, and is the Company's ultimate parent.
The Company is a life insurance company licensed to sell annuity, group and individual life, group and individual accident and health policies in six states and the District of Columbia. Based on statutory net premium written, the Company's business is predominately annuity. The annuity business consists of variable-indexed annuities and closed blocks of variable, fixed and fixed-indexed annuities. The life business includes term life policies and closed blocks of universal life policies. Accident and health business is primarily comprised of closed blocks of long-term care (LTC) insurance. The Company's primary distribution channel is through broker-dealers.
After evaluating the Company’s ability to continue as a going concern, management is not aware of any conditions or events which raise substantial doubt concerning the Company’s ability to continue as a going concern as of the date of filing these Statutory Financial Statements.
(2) Summary of Significant Accounting Policies
(a) Basis of Presentation
The Statutory Financial Statements have been prepared in accordance with accounting practices prescribed or permitted by the New York State Department of Financial Services (the Department). The Department recognizes statutory accounting practices prescribed or permitted by the state of New York for determining and reporting the financial condition and results of operations of an insurance company and its solvency under New York insurance law. The state of New York has adopted the National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual as its prescribed basis of statutory accounting principles (SAP). The state of New York has also adopted certain prescribed accounting practices that differ from those found in NAIC SAP. The Company has no material statutory accounting practices that differ from those of the Department or NAIC SAP. These practices differ in some respects from accounting principles generally accepted in the United States of America (U.S. GAAP). The effects of these differences, while not quantified, are presumed to be material to the Statutory Financial Statements. The more significant of these differences are as follows:
(1) Acquisition costs, such as commissions and other costs incurred in connection with acquiring new and renewal business, are charged to current operations as incurred. Under U.S. GAAP, acquisition costs that are directly related to the successful acquisition of insurance contracts are capitalized and charged to operations on a straight-line basis over the expected term of the related contracts.
(2) Aggregate reserves for life policies and annuity contracts, excluding variable annuities, are based on statutory mortality and interest assumptions without consideration for lapses or withdrawals. Under U.S. GAAP, aggregate reserves consider lapses and withdrawals.
(3) Ceded reinsurance recoverable are netted against their related reserves within Policyholder liabilities, Life policies and annuity contracts and Life policy and contract claims, on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Under U.S. GAAP, these ceded reserves are presented on a gross basis as an asset.
(4) Bonds are carried at values prescribed by the NAIC, generally amortized cost, except for those with an NAIC rating of 6, which are reported at the lower of amortized cost or fair value. Under U.S. GAAP, bonds classified as “available-for-sale” are carried at fair value, with unrealized gains and losses recorded in stockholder’s equity.
(5) Changes in deferred income taxes are recorded directly to Unassigned surplus. Under U.S. GAAP, these items are generally recorded as an item of income tax benefit or expense in operations. Moreover, under NAIC SAP, a valuation allowance may be recorded against the deferred tax asset (DTA) and admittance
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
testing may result in an additional charge to capital and surplus for nonadmitted portions of DTAs. Under U.S. GAAP, a valuation allowance may be recorded against the DTA and reflected as an expense.
(6) The Company is required to establish an asset valuation reserve (AVR) liability and an interest maintenance reserve (IMR) liability. The AVR provides for a standardized statutory investment valuation reserve for certain invested assets. Changes in this reserve are recorded as direct charges or credits to Unassigned surplus. The IMR is designed to defer net realized capital gains and losses, net of tax, resulting from changes in the level of prevailing market interest rates and amortize them into income within the Statutory Statements of Operations over the remaining life of the investment sold. The IMR represents the unamortized portion of applicable investment gains and losses as of the balance sheet date. There is no such concept under U.S. GAAP.
(7) Certain assets designated as “nonadmitted assets” are not recognized and are charged directly to Unassigned surplus within the Statutory Statements of Capital and Surplus. These include, but are not limited to, furniture and fixtures, prepaid expenses, receivables outstanding greater than 90 days, negative IMR, and portions of DTAs. There is no such concept under U.S. GAAP.
(8) A provision is made for amounts ceded to unauthorized reinsurers in excess of collateral in the form of a trust or letter of credit through a direct charge to Unassigned surplus within the Statutory Statements of Capital and Surplus. There is no such requirement under U.S. GAAP.
(9) Revenues for universal life policies and annuity contracts, excluding deposit-type contracts, are recognized as revenue when received within the Statutory Statements of Operations. Under U.S. GAAP, policy and contract fees charged for the cost of insurance, policy administrative charges, amortization of policy initiation fees, and surrender contract charges are recorded as revenues when earned.
(10) Benefits for universal life policies and annuity contracts within the Statutory Statements of Operations, excluding deposit-type contracts, consist of payments made to policyholders. Under U.S. GAAP, benefits represent interest credited, and claims and benefits incurred in excess of the policyholder’s contract balance.
(11) Changes in the fair value of derivatives are recorded as direct adjustments to Unassigned surplus as a component of Change in unrealized capital gains (losses) within the Statutory Statements of Capital and Surplus. Under U.S. GAAP, changes in the fair value of derivatives are recorded in derivative income (loss) as part of operating income.
(12) Commissions allowed by reinsurers on business ceded are reported as income when received within the Statutory Statements of Operations. Under U.S. GAAP, such commissions are deferred and amortized as a component of deferred acquisition costs to the extent recoverable.
(13) The Statutory Financial Statements do not include a statement of comprehensive income as required under U.S. GAAP.
(14) The Statutory Statements of Cash Flow do not classify cash flows consistent with U.S. GAAP and a reconciliation of net income to net cash provided from operating activities is not provided.
(15) The calculation of reserves and transfers in the separate account statement requires the use of a Commissioners Annuity Reserve Valuation Method (CARVM) allowance on annuities for NAIC SAP. There is no such requirement under U.S. GAAP.
(16) Sales inducements and premium bonuses are included in Life policies and annuity contracts in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus, and are charged to current operations as incurred. Under U.S. GAAP, deferred sales inducements and premium bonuses are similarly reserved; however, the costs are capitalized as assets and charged to operations as future profits are recognized in a manner similar to acquisition costs.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(17) Negative cash balances are presented as a negative asset within the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. These balances are presented as a liability under U.S. GAAP.
(18) Embedded derivatives are not separated from the host contract and accounted for separately as a derivative instrument. Under U.S. GAAP, entities must separate the embedded derivative from the host contracts and separately account for those embedded derivatives at fair value.
(19) For variable-indexed annuities, the Department requires the Company to maintain a separate asset portfolio to back related reserves. These assets and liabilities are required to be included as part of the Separate account assets and Separate account liabilities presented on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Under U.S. GAAP, there is no such requirement.
(b) Permitted and Prescribed Statutory Accounting Practices
The Company is required to file annual statements with insurance regulatory authorities, which are prepared on an accounting basis permitted or prescribed by such authorities. Prescribed statutory accounting practices include state laws, regulations, and general administrative rules, as well as a variety of publications of the NAIC. Permitted statutory accounting practices encompass all accounting practices that are not prescribed; such practices differ from state to state, may differ from company to company within a state, and may change in the future. The Company has no permitted or prescribed practices that differ from NAIC SAP that had an impact on net income or surplus as of December 31, 2023, 2022, and 2021.
(c) Use of Estimates
The preparation of Statutory Financial Statements in conformity with NAIC SAP requires management to make certain estimates and assumptions that affect reported amounts of admitted assets and liabilities, including reporting or disclosure of contingent assets and liabilities as of December 31, 2023 and 2022, and the reported amounts of revenues and expenses during the reporting period. Future events, including changes in mortality, morbidity, interest rates, capital markets, and asset valuations could cause actual results to differ from the estimates used within the Statutory Financial Statements. Such changes in estimates are recorded in the period they are determined.
(d) Premiums and Annuity Considerations
Life premiums are recognized as income over the premium paying period of the related policies. Nondeposit-type annuity considerations are recognized as revenue when received. Accident and health premiums are earned ratably over the terms of the related insurance and reinsurance contracts or policies.
(e) Aggregate Reserves for Life Policies and Annuity Contracts
Reserves are principally calculated as the minimum reserves permitted by the state where the contract is issued for the year in which the contract is issued.
For the Company’s fixed annuity product lines, reserves are calculated using CARVM. The Company uses both issue year for fixed-indexed and change in fund basis for deferred fixed-interest annuities for the calculation method, on a continuous basis, using the maximum allowable interest rate. Deferred fixed-indexed and fixed-interest annuities only have a single-tier structure, which may include bonuses.
For the Company’s variable and variable-indexed annuity product lines, reserves are calculated using NY Regulation 213, for guaranteed benefits with adequacy confirmed using stochastic scenario testing. Variable deferred annuities include a wide range of guaranteed minimum death benefits and living benefits (income, accumulation, and withdrawal).
Aggregate reserves for life insurance policies are principally calculated using the Commissioners Reserve Valuation Method (CRVM) or VM-20, Requirements for Principle-Based Reserves for Life Products, depending on the policy's issue date. Additional reserves are held for supplemental benefits and for contracts with secondary guarantees, consistent with prescribed regulations and actuarial guidelines.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
The Company performs an annual asset adequacy analysis as required by regulation covering substantially all of its reserves. These tests are not only performed under the required interest rate scenarios, but also under additional stochastically generated interest and equity growth scenarios. Sensitivity tests, including policy lapse, annuitization, maintenance expenses, and investment return, are performed to evaluate potential insufficiencies in reserve adequacy. The results of these tests and analysis resulted in additional adequacy reserves recorded of $57,000 at December 31, 2023 and 2022. For the universal life business, the Department’s Regulation 147 – Valuation of Life Insurance Reserves stand-alone asset adequacy analysis was performed, which resulted in establishing additional reserves of $100 as of December 31, 2023 and 2022.
(f) Aggregate Reserves for Accident and Health Policies
For accident and health business, reserves consist of active life reserves (mainly reserves for unearned premiums and reserves for contingent benefits on individual LTC business) and claim reserves (the present value of amounts not yet due). Claim reserves represent incurred but unpaid claims under group policies. For the LTC business, the Department’s Regulation 56 – Minimum Reserves for Individual Accident and Health Insurance Policies stand‑alone asset adequacy analysis was performed through a gross premium valuation. The testing under the “sound value” requirements resulted in recorded reserves of $36,504 as of December 31, 2023 and 2022.
(g) Deposit-type Contracts
Deposit-type contracts represent liabilities to policyholders in a payout status, who have chosen a fixed payout option without life contingencies. The premiums and claims related to deposit-type contracts are not reflected in the Statutory Statements of Operations as they do not have insurance risk. The Company accounts for the contract as a deposit-type contract in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(h) Policy and Contract Claims
Policy and contract claims include the liability for claims reported but not yet paid, claims incurred but not yet reported (IBNR), and claim settlement expenses on the Company’s accident and health business. Actuarial reserve development methods are generally used in the determination of IBNR liabilities. In cases of limited experience or lack of credible claims data, loss ratios are used to determine an appropriate IBNR liability. Claim and IBNR liabilities of a short-term nature are not discounted, but those claim liabilities resulting from disability income or LTC benefits include interest and mortality discounting.
(i) Reinsurance
The Company cedes business to other insurers. Reinsurance premium and benefits paid or provided are accounted for in a manner consistent with the basis used in accounting for original policies issued and the terms of the reinsurance contracts. Amounts recoverable from reinsurers represent account balances and unpaid claims covered under reinsurance contracts. Amounts paid or deemed to have been paid for claims covered by reinsurance contracts are recorded as a reinsurance recoverable and are included in Other assets on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(j) Investments
Investment values are determined in accordance with methods prescribed by the NAIC.
Bonds
The Securities Valuation Office (SVO) of the NAIC evaluates the credit quality of the Company’s bond investments. Bonds rated at “1” (highest quality), “2” (high quality), “3” (medium quality), “4” (low quality), or “5” (lower quality) are reported at cost adjusted for the amortization of premiums, accretion of discounts, and any impairment. Bonds rated at “6” (lowest quality) are carried at the lower of amortized cost or fair value with any adjustments to fair value recorded to Unassigned surplus within the Statutory Statements of Capital and Surplus.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
In accordance with its investment policy, the Company invests primarily in high-grade marketable securities. Dividends are accrued on the date declared and interest is accrued as earned. Premiums or discounts on bonds are amortized using the constant-yield method.
Loan-backed securities and structured securities are amortized using anticipated prepayments, in addition to other less significant factors. Prepayment assumptions for loan-backed and structured securities are obtained from various external sources or internal estimates. The Company believes these assumptions are consistent with those a market participant would use. The Company recognizes income using the modified scientific method based on prepayment assumptions and the estimated economic life of the securities. For structured securities, except impaired bonds, when actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date and anticipated future payments retrospectively. Any resulting adjustment is included in Net investment income on the Statutory Statements of Operations. For impaired bonds, when adjustments are made for anticipated prepayments and other expected changes in future cash flows, the effective yield is recalculated using the prospective method as required by Statement of Statutory Accounting Principles (SSAP) No. 43R – Loan Backed and Structured Securities (SSAP No. 43R).
Hybrid securities are investments structured to have characteristics of both stocks and bonds. The Company records these securities within Bonds on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
Gross realized gains and losses are computed based on the average amortized cost of all lots held for a particular CUSIP.
The fair value of bonds is obtained from third-party pricing sources whenever possible. Management completes its own independent price verification (IPV) process, which ensures security pricing is obtained from a third-party source other than the sources used by the Company's internal and external investment managers. The IPV process supports the reasonableness of price overrides and challenges by the internal and external investment managers and reviews pricing for appropriateness. Results of the IPV process are reviewed by the Company’s Pricing Committee.
Allianz Life reviews its entire combined investment portfolio, including the investment portfolios of the Company and all other subsidiaries, in aggregate each quarter to determine if declines in fair value are other than temporary.
For bonds for which the fair value is less than amortized cost, the Company evaluates whether a credit loss exists by considering primarily the following factors: (a) the length of time and extent to which the fair value has been less than the amortized cost of the security; (b) changes in the financial condition, credit rating, and near-term prospects of the issuer; (c) whether the issuer is current on contractually obligated interest and principal payments; (d) changes in the financial condition of the security’s underlying collateral, if any; and (e) the payment structure of the security. For loan-backed securities, the Company must allocate other-than-temporary impairments (OTTI) between interest and noninterest-related declines in fair value. Interest-related impairments are considered other than temporary when the Company has the intent to sell the investment prior to recovery of the cost of the investment. The Company maintains a prohibited disposal list that restricts the ability of the investment managers to sell securities in a significant unrealized loss position and requires formal attestations from investment managers regarding their lack of intent to sell certain securities.
Impairments considered to be other-than-temporary are recorded as a reduction of the cost of the security, and a corresponding realized loss is recognized on the Statutory Statements of Operations in the period in which the impairment is determined. Recognition of the realized loss is subject to potential offset by AVR and IMR.
Cash and Cash Equivalents
Cash and cash equivalents may include cash on hand, demand deposits, money market funds, and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the carrying value is deemed to approximate fair value.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
Policy Loans
Policy loans are supported by the underlying cash value of the policies. Policy loans are carried at unpaid principal balances plus accrued interest income on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. The unpaid principal balances are not in excess of the cash surrender values of the related policies.
Receivables for Securities
Receivables and payables for securities are carried at fair value on the trade date and represent a timing difference on securities that are traded at the balance sheet date but not settled until subsequent to the balance sheet date. Receivables and payables for securities are included in Receivables for securities and Other liabilities, respectively, on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(k) Derivatives
The Company utilizes derivatives within certain actively managed investment portfolios for hedging purposes.
Futures and Options Contracts
The Company provides benefits through certain annuity products which are linked to the fluctuation of various market indices, and certain variable annuity contracts that provide minimum guaranteed benefits. The Company has analyzed the characteristics of these benefits and has entered into over-the-counter (OTC) option contracts and exchange-traded futures contracts tied to an underlying index with similar characteristics with the objective to economically hedge these benefits. Management monitors in-force amounts as well as option and futures contract values to ensure satisfactory matching and to identify unsatisfactory mismatches. If actual persistency deviated, management would purchase or sell option and futures contracts as deemed appropriate or take other actions.
The OTC option contracts are reported at fair value in Derivative assets and Derivative liabilities on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. The fair value of the OTC options is derived internally and deemed by management to be reasonable via performing an IPV process. The process of deriving internal derivative prices requires the Company to calibrate Monte Carlo scenarios to actual market information. The calibrated scenarios are applied to derivative cash flow models to calculate fair value prices for the derivatives. Incremental gains and losses from expiring options are included in Net realized capital gain (loss) on the Statutory Statements of Operations. The liability for the related policyholder benefits is reported in Life policies and annuity contracts on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. The unrealized gain or loss on open OTC option contracts is recognized as a direct adjustment to Unassigned surplus within the Statutory Statements of Capital and Surplus. Any unrealized gains or losses on open OTC option contracts are recognized as realized when the contracts mature (see Note 5 for further discussion).
Futures contracts do not require an initial cash outlay, and the Company has agreed to daily net settlement based on movements of the representative index. Therefore, no asset or liability is recorded as of the end of the reporting period. A derivative asset or liability and an offsetting variation margin payable or receivable is recorded in Derivative assets or Derivative liabilities in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus for the outstanding unpaid variation margin representing market movements on the last trading day of the year.
Gains and losses are not considered realized until the termination or expiration of the futures contract. Unrealized gains and losses on futures contracts are reflected in the Statutory Statements of Capital and Surplus in Unassigned surplus, within Change in unrealized capital gains (loss). Realized gains and losses on futures contracts are included in the Statutory Statements of Operations, Net realized capital gain (loss), net of taxes and interest maintenance reserve.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(l) Income Taxes
The Company files a consolidated federal income tax return with AZOA. The consolidated tax allocation agreement stipulates that each company participating in the return will bear its share of the tax liability pursuant to certain tax allocation elections under the Internal Revenue Code (IRC) and its related regulations and reimbursement will be in accordance with an intercompany tax reimbursement arrangement. The Company generally will be paid for the tax benefit of any of their tax attributes used by any member of the consolidated group.
The Company provides for federal income taxes based on amounts the Company believes it ultimately will owe. Inherent in the provision for federal income taxes are estimates regarding the deductibility of certain items and the realization of certain tax credits. In the event the ultimate deductibility of certain items or the realization of certain tax credits differs from estimates, the Company may be required to significantly change the provision for federal income taxes recorded in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Any such change could significantly affect the amounts reported in the Statutory Statements of Operations. Management uses best estimates to establish reserves based on current facts and circumstances regarding tax exposure items where the ultimate deductibility is open to interpretation. Quarterly, management evaluates the appropriateness of such reserves based on any new developments specific to their fact patterns. Information considered includes results of completed tax examinations, Technical Advice Memorandums, and other rulings issued by the Internal Revenue Service or the tax courts.
The Company utilizes the asset and liability method of accounting for income taxes. DTAs and deferred tax liabilities (DTLs), net of the nonadmitted portion are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Gross DTAs and DTLs are measured using enacted tax rates and are considered for admitted tax asset status according to the admissibility test as set forth by the state of New York. Changes in DTAs and DTLs, including changes attributable to changes in tax rates, are recognized as a component of Unassigned surplus on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(m) Separate Accounts
Separate account assets and liabilities are primarily funds held for the exclusive benefit of variable and variable-indexed annuity contract holders. Separate account assets are reported at fair value in accordance with SSAP No. 56 – Separate Accounts (SSAP No. 56), with the exception of certain bonds, cash, cash equivalents, and investment income due and accrued. Certain assets that are allocated to the index options for the Allianz Index Advantage New York Variable Annuity (VIA), as listed above, are carried at amortized cost in accordance with the product filing requirements in the state of New York.
Amounts due from separate accounts primarily represent the difference between the surrender value of the contracts and the Separate account liability as disclosed on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. This receivable represents the surrender fee that would be paid to the Company upon the surrender of the policy or contract by the policyholder or contract holder as of December 31. Amounts charged to the contract holders for mortality and contract maintenance, and other administrative services fees are included in income within Fees from separate accounts on the Statutory Statements of Operations. These fees have been earned and assessed against contract holders on a daily or monthly basis throughout the contract period and are recognized as revenue when assessed and earned. Transfers to separate accounts within the Statutory Statements of Operations primarily includes transfers for new premium and annuity considerations, benefit payments, surrender charge wear-off, realized and unrealized investment gains/losses, investment income, and other contractholder behavior.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(n) Receivables
Receivable balances approximate estimated fair values. This is based on pertinent information available to management as of year-end, including the financial condition and creditworthiness of the parties underlying the receivables. Any balances outstanding more than 90 days are nonadmitted on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(o) Reclassifications
On the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus, there were policyholder suspense items within Other liabilities that were material enough to warrant their own line item, and therefore, were reclassified to Other policyholder funds. The prior year balance was reclassified to conform to the current year presentation.
(3) Accounting Changes and Corrections of Errors
Accounting Changes
During 2023, the Company changed its accounting policy for internal exchanges, which are 1035 tax-free exchanges initiated by the policyholder to transition from an existing annuity contract to a new like kind annuity contract. Historically, the transaction was recorded net, with no financial statement impact. The Company has concluded that the transaction should be accounted for as a surrender of the existing contract within Surrenders on the Statement of Operations and a subsequent application of premium on the new contract within Premiums and annuity considerations on the Statement of Operations. This change in accounting policy was effective January 1, 2023. As the increase in both Premium and annuity considerations and Surrenders net to zero, there is no change to net income or surplus for the year ended December 31, 2022.
Recently Issued Accounting Standards – Adopted in 2023
In March 2020, the NAIC adopted NS 2020-12, Reference Rate Reform, which provides optional guidance for a limited period of time to ease the potential burden on accounting for reference rate reform. The expedients outlined in the amendment are for modifications solely related to reference rate reform and optionally suspend assessments for re-measuring a contract. The Company adopted these amendments effective March 12, 2020. In August 2023, the NAIC adopted NS 2023-05, whereby the sunset date for relief afforded by NS 2020-12, was deferred until December 31, 2024. The Company has evaluated the impact of the new guidance and has identified financial assets which have terms related to reference rates that are expected to be discontinued. As of December 31, 2023, the Company has utilized the optional expedient to account for all modifications to financial assets occurring as a result of reference rate reform as a continuation of the existing financial asset. There was no impact on net income or surplus during the year-ended December 31, 2023, as a result of adopting the revisions.
In August 2023, the NAIC adopted INT 23-01 Negative IMR. The temporary relief, which is optional for all companies required to maintain an AVR and IMR, allows for those entities to admit a limited amount of a net negative IMR balance as an admitted asset on a reporting entity's balance sheet. The revisions are effective as of August 13, 2023, and will be automatically nullified on January 1, 2026. The Company has adopted and implemented this INT for the purposes of December 31, 2023 reporting. Financial impacts associated with the implementation of this adoption are contained within Note 5(i), per the disclosure requirements associated with INT 23-01.
Recently Issued Accounting Standards – Adopted in 2022
Not applicable.
Recently Issued Accounting Standards – Adopted in 2021
In 2021, the NAIC extended the following interpretations (INT) in response to the COVID-19 pandemic:
•INT 20-03, Troubled Debt Restructuring due to COVID-19. This INT followed the interagency COVID-19 guidance issued by federal and state prudential banking regulators (and concurred by the FASB) and the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Specifically, a modification of a mortgage loan or bank loan terms did not result in troubled debt restructurings as long as
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
the modification was in response to COVID-19, the borrower was current at the time of the modification, and the modification was short-term. In addition, insurers were not required to designate mortgage loans or bank loans with deferrals granted due to COVID-19 as past due or report them as nonaccrual loans. This INT was effective for the period beginning March 1, 2020 and originally expired on December 31, 2020. In January 2021, the provisions in this INT were extended updating the effective period to be the earlier of January 1, 2022 or the date that is 60 days after the date on which the national emergency declared by the President terminates. This INT did not impact the Company.
•INT 20-07, Troubled Debt Restructuring of Certain Debt Investments Due to COVID-19. This INT provided temporary guidance by allowing practical expedients when assessing whether modifications made to debt securities (under SSAP No. 26R and SSAP No. 43R) due to COVID-19 are insignificant. Specifically, the guidance proposed restructurings in response to COVID-19 are considered to be insignificant if the restructuring resulted in a 10% or less shortfall amount in the contractual amount due and did not extend the maturity of the investment by more than 3 years. This INT was effective for the period beginning March 1, 2020 and originally expired on December 31, 2020. In January 2021, the provisions in this INT were extended updating the effective period to be the earlier of January 1, 2022 or the date that is 60 days after the date on which the national emergency declared by the President terminates. This INT did not impact the Company.
In 2016, the NAIC adopted revisions to SSAP No. 51R, Life Contracts and SSAP No. 54, Individual and Group Accident and Health Contracts, Issue Paper No. 154, Implementation of Principles-Based Reserving. These revisions relate to the adoption of the Valuation Manual and provides for principles based reserving for Life and Heath contracts. The Valuation Manual is part of the Department Regulation 213. Final adoption of the First Amendment to Regulation 213 was published February 2020 and provides the following revisions: 1) VM-20, Requirements for Principle-Based Reserves for Life Products, is effective January 1, 2020. However, an insurer could request a one-year delay in adopting this standard. The Company adopted Regulation 213 for life products as of January 1, 2021 for new business issued January 1, 2021 and later, in accordance with its agreement with the Department. The adoption resulted in an immaterial impact. 2) VM-21, Requirements for Principle-Based Reserves for Variable Annuities was adopted in 2020. 3) VM-22, Statutory Maximum Valuation Interest Rates for Income Annuities, VM-25, Health Insurance Reserves Minimum Requirements, and VM-26, Credit Life and Disability Reserve Requirements, are not applicable as the Company does not issue these contracts.
Recently Issued Accounting Standards – To Be Adopted
In August 2023, the NAIC adopted revisions to SSAP No. 26R and SSAP No. 43R, and updated references for various SSAPs to accommodate the two newly revised and adopted standards. Both revised SSAPs as well as the updated references were adopted as part of SAPWG's Principles Based Bond Definition project, and represent the first step towards implementing the new bond definition. The revised standards will be effective starting January 1, 2025. The Company is currently assessing the impacts of the amendments.
In December 2023, the NAIC adopted revisions to the Annual Statement Instructions through Ref #2023-15: IMR/AVR Specific Allocations. The revisions clarify the treatment of realized gains or losses in the context of allocating those gains and losses to either AVR or IMR. While the amendment reflects a SAP Clarification, the amendment addresses a new concept in basing the allocation of realized gains or losses on an "Acute Credit Event." The amendment is effective beginning January 1, 2024, and the Company plans to adopt these revisions as of that date. As this amendment applies to future transactions, there will be no impact to net income or surplus upon adoption.
Corrections of Errors
The Company records corrections of errors in accordance with SSAP No. 3 – Accounting Changes and Correction of Errors (SSAP No. 3). SSAP No. 3 prescribes that the correction of errors in previously issued Statutory Financial Statements will be reported as an adjustment to capital and surplus in the period the error is detected. These errors are shown within Correction of errors, net of tax, on the Statutory Statements of Capital and Surplus.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
During 2023, an error was identified related to the non-admittance of negative IMR that resulted from separate account assets. As of December 31, 2022, the Company had produced a negative IMR in both the general account and the separate account, and therefore, should have non-admitted all negative IMR. The negative IMR in the general account was appropriately being fully non-admitted, however, the impacts from the non-admitted IMR in the separate account were not being reflected appropriately in the general account. The error resulted in a $2,198 overstatement of Due from the separate accounts and a corresponding $2,198 overstatement of Total capital and surplus within the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus as of December 31, 2022. The Statutory Statements of Capital and Surplus was adjusted in 2023 to correct for the prior period impact.
During the years ended December 31, 2022 and 2021 there were no corrections of errors recorded on the Statutory Statements of Capital and Surplus.
(4) Risk Disclosures
The following is a description of the significant risks facing the Company and how it attempts to mitigate those risks:
(a) Credit Risk
Credit risk is the risk that issuers of fixed-income securities, or other parties with whom the Company has transactions, such as reinsurers and derivative counterparties, default on their contractual obligations, resulting in unexpected credit losses.
The Company mitigates this risk by adhering to investment policies and limits that provide portfolio diversification on an asset class, asset quality, creditor, and geographical basis, and by complying with investment limitations from applicable state insurance laws and regulations. The Company considers all relevant objective information available in estimating the cash flows related to structured securities. The Company actively monitors and manages exposures, and determines whether any securities are impaired. The aggregate credit risk is influenced by management’s risk/return preferences, the economic and credit environment, and the ability to manage this risk through liability portfolio management.
For derivative counterparties, the Company mitigates credit risk by tracking and limiting exposure to each counterparty through limits that are reported regularly and, once breached, restricts further trades; establishing relationships with counterparties rated BBB+ and higher; and monitoring the credit default swaps (CDS) of each counterparty as an early warning signal to cease trading when credit default swap spreads imply severe impairment in credit quality.
The Company executes Credit Support Annexes (CSA) with all active and new counterparties which further limits credit risk by requiring counterparties to post collateral to a segregated account to cover any counterparty exposure. Additionally most transactions are cleared through a clearinghouse thereby transferring counterparty risk from the bank to the clearinghouse that tends to have stronger credit. This often leads to increased collateralization and lower counterparty risk for the Company.
(b) Credit Concentration Risk
Credit concentration risk is the risk of increased exposure to significant asset defaults (of a single security issuer); economic conditions (if business is concentrated in a certain industry sector or geographic area); or adverse regulatory or court decisions (if concentrated in a single jurisdiction) affecting credit.
The Company’s Finance Committee, responsible for asset/liability management (ALM) issues, recommends an investment policy to the Company’s Board of Directors (BOD) and approves the strategic asset allocation and accompanying investment mandates for an asset manager with respect to asset class. The investment policy and accompanying investment mandates specify asset allocation among major asset classes and the degree of asset manager flexibility for each asset class. The investment policy complies, at a minimum, with state statutes. Compliance with the policy is monitored by the Finance Committee who is responsible for implementing internal controls and procedures. Deviations from the policy are monitored and addressed. The Finance Committee and, subsequently, the BOD review the investment policy at least annually.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
To further mitigate this risk, internal concentration limits based on credit rating and sector are established and are monitored regularly by Allianz Life on a consolidated basis. Any ultimate obligor group exceeding these limits is placed on a restricted list to prevent further purchases, and the excess exposure may be actively sold down to comply with concentration limit guidelines. Any exceptions require Chief Risk Officer approval and monitoring by the Risk Committee. Further, the Company performs a quarterly concentration risk calculation to ensure compliance with the State of New York basket clause.
(c) Liquidity Risk
Liquidity risk is the risk that unexpected timing or amounts of cash needed will require liquidation of assets in a market that will result in a realized loss or an inability to sell certain classes of assets such that an insurer will be unable to meet its obligations and contractual guarantees. Liquidity risk also includes the risk that in the event of a company liquidity crisis, refinancing is only possible at higher interest rates. Liquidity risk can be affected by the maturity of liabilities, the presence of withdrawal penalties, the breadth of funding sources, and terms of funding sources. It can also be affected by counterparty collateral triggers as well as whether anticipated liquidity sources, such as credit agreements, are cancelable.
The Company manages liquidity within four specific domains: (1) monitoring product development, product management, business operations, and the investment portfolio; (2) setting ALM strategies; (3) managing the cash requirements stemming from the Company’s derivative dynamic economic hedging activities; and (4) establishing a liquidity facility with Allianz Life to provide additional liquidity. The Company has established liquidity risk limits, which are approved by the Company’s Risk Committee, and the Company monitors its liquidity risk regularly.
(d) Interest Rate Risk
Interest rate risk is the risk that movements in interest rates or interest rate volatility will cause a decrease in the value of an insurer’s assets relative to the value of its liabilities and/or an unfavorable change in prepayment activity resulting in compressed interest margins.
The Company has an ALM strategy to align cash flows and duration of the investment portfolio with policyholder liability cash flows and duration. Allianz Life monitors the economic and accounting impacts of interest rate sensitivities on assets and liabilities on a consolidated basis regularly and on the Company's specific basis periodically.
(e) Equity Market Risk
Equity market risk is the risk that movements in equity prices or equity volatility will cause a decrease in the value of an insurer’s assets relative to the value of its liabilities.
Variable annuity products guarantee minimum payments regardless of market movements. The Company has adopted an economic hedging program to manage the equity risk of these products.
Allianz Life monitors the impacts of equity sensitivities on assets and liabilities on a consolidated basis regularly and on the Company’s specific basis periodically.
Basis risk is the risk that variable annuity hedge asset values change unexpectedly relative to the value of the underlying separate account funds of the variable annuity contracts. Basis risk may arise from the Company’s inability to directly hedge the underlying investment options of the variable annuity contracts. The Company regularly reviews and synchronizes fund mappings, product design features, hedge design, and manages funds line-up.
(f) Operational Risk
Operational risk is the risk of loss resulting from inadequate or failed internal processes and systems, from human misbehavior or error, or from external events. Operational risk is comprised of the following seven risk categories: (1) external fraud; (2) internal fraud; (3) employment practices and workplace safety; (4) clients/third-party, products and business practices; (5) damage to physical assets; (6) business disruption and system
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
failure; and (7) execution, delivery, and process management. Operational risk is comprehensively managed through a combination of core qualitative and quantitative activities.
The Operational Risk Management framework includes the following key activities: (1) an Operational Risk Capital Model covering all material types of operational risks, under which the Company quantifies and regularly monitors operational risk; (2) a loss data capture policy to create transparency and gather information about losses that meet a designated threshold, requiring business owners to identify and resolve the root cause of operational loss events; and (3) a bottom-up risk assessment process for significant operational risk scenarios to proactively manage significant operational risk scenarios throughout the organization.
(g) Regulatory Change Risk
Regulatory change risk is the risk that regulatory changes and imposed regulation may materially impact the Company's business model, sales levels, company financials and ability to effectively comply with regulations.
The Company actively monitors all regulatory changes and participates in national and international discussions relating to legal, regulatory, and accounting changes. The Company maintains active membership with various professional and industry trade organizations. A formal process exists to review, analyze, and implement new legislation as it is enacted.
(h) Rating Agency Risk
Rating agency risk is the risk that rating agencies change their outlook or rating of the Company. The rating agencies generally utilize proprietary capital adequacy models in the process of establishing ratings for the Company. The Company is at risk of changes in these models and the impact that changes in the underlying business that it is engaged in can have on such models. To mitigate this risk, the Company maintains regular communications with the rating agencies and evaluates the impact of significant transactions on such capital adequacy models and considers the same in the design of transactions to minimize the adverse impact of this risk. Rating agency risk is also addressed in the TRA process and on an ad hoc basis as necessary.
(i) Mortality/Longevity Risk
Mortality/longevity risk is the risk that mortality experience is different than the life expectancy assumptions used by the Company to price its products.
The Company mitigates mortality risk primarily through reinsurance, whereby the Company cedes a significant portion of its mortality risk to third parties. The Company also manages mortality risk through the underwriting process. Both mortality and longevity risks are managed through the review of life expectancy assumptions and experience in conjunction with active product management.
(j) Lapse Risk
Lapse risk is the risk that actual lapse experience evolves differently than the assumptions used for pricing and valuation exercises leading to a significant loss in Company value and/or income.
The Company mitigates this risk by performing sensitivity analysis at the time of pricing to affect product design, adding Market Value Adjustments and surrender charges when appropriate, regular ALM analysis, and exercising management levers at issue, as well as post-issue as experience evolves. Policyholder experience is monitored regularly.
(k) Cyber Security Risk
Cyber security risk is the risk of losses due to external and/or internal attacks impacting the confidentiality, integrity, and/or availability of key systems, data, and processes reliant on digital technology. The Company has implemented preventative, detective, response, and recovery measures including firewalls, intrusion detection and prevention, advanced malware detection, spyware and anti-virus software, email protection, network and laptop encryption, web content filtering, web application firewalls, and regular scanning of all servers and network devices to identify vulnerabilities. Controls are implemented to prevent and review unauthorized access.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(l) Reinsurance Risk
Reinsurance risk is the risk that reinsurance companies default on their obligation where the Company has ceded a portion of its insurance risk. The Company uses reinsurance to limit its risk exposure to certain business lines and to enable better capital management.
Reinsurance contracts do not relieve the Company from its obligations to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company.
The Company mitigates this risk by requiring certain counterparties to post collateral to cover the exposure and to meet thresholds related to the counterparty’s credit rating, exposure, or other factors. For counterparties that are not initially required to post collateral, if the thresholds are not met by those counterparties, they are required to establish a trust or letter of credit backed by assets meeting certain quality criteria. All arrangements are regularly monitored to determine whether trusts or letters of credit are sufficient to support the ceded liabilities and that their terms are being met. In addition, the Company reviews the financial standings and ratings of its reinsurance counterparties and monitors concentrations of credit risk to minimize its exposure to significant losses from reinsurer insolvencies regularly.
(5) Investments
(a) Bonds and Other Assets Receiving Bond Treatment
At December 31, the amortized cost, gross unrealized gains, gross unrealized losses, and fair values of investments are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
| Amortized cost |
| Gross unrealized gains |
| Gross unrealized losses |
| Fair value |
Bonds: |
|
|
|
|
|
|
|
|
U.S. government |
| $ | 142,582 |
|
| — |
|
| 8,161 |
|
| 134,421 |
|
States and political subdivisions |
| 8,623 |
|
| 38 |
|
| 677 |
|
| 7,984 |
|
| | | | | | | | |
Corporate securities |
| 364,970 |
|
| 6,390 |
|
| 27,399 |
|
| 343,961 |
|
Mortgage-backed securities |
| 102,497 |
|
| 63 |
|
| 8,638 |
|
| 93,922 |
|
Total |
| $ | 618,672 |
|
| 6,491 |
|
| 44,875 |
|
| 580,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
| Amortized cost |
| Gross unrealized gains |
| Gross unrealized losses |
| Fair value |
Bonds: |
|
|
|
|
|
|
|
|
U.S. government |
| $ | 192,732 |
|
| — |
|
| 12,000 |
|
| 180,732 |
|
States and political subdivisions |
| 6,788 |
|
| 22 |
|
| 776 |
|
| 6,034 |
|
| | | | | | | | |
Corporate securities |
| 340,514 |
|
| 2,477 |
|
| 37,920 |
|
| 305,071 |
|
Mortgage-backed securities |
| 107,388 |
|
| 8 |
|
| 10,707 |
|
| 96,690 |
|
Total |
| $ | 647,422 |
|
| 2,507 |
|
| 61,403 |
|
| 588,527 |
|
At December 31, 2023 and 2022, the Company did not have NAIC-6 rated bonds.
At December 31, 2023 and 2022, the Company did not have any hybrid securities.
As of December 31, 2023 and 2022, investments with an amortized cost of $1,662 and $1,651, respectively were held on deposit as required by statutory regulations.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
The amortized cost and fair value of bonds and other assets receiving bond treatment reported in the statutory Annual Statement Schedule D Part 1A at December 31, 2023, by contractual maturity, are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amortized cost |
| Fair value |
Due in 1 year or less |
| $ | 13,653 |
|
| 13,445 |
|
Due after 1 year through 5 years |
| 174,094 |
|
| 168,850 |
|
Due after 5 years through 10 years |
| 71,238 |
|
| 70,607 |
|
Due after 10 years through 20 years |
| 202,492 |
|
| 180,523 |
|
Due after 20 years |
| 54,698 |
|
| 52,941 |
|
Loan-backed and other structured securities |
| 102,497 |
|
| 93,922 |
|
Total bonds and other assets receiving bond treatment |
| $ | 618,672 |
|
| 580,288 |
|
Expected maturities will differ from contractual maturities, because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Proceeds from sales of bonds includes sales, maturities, paydowns, and other redemptions of bonds and other assets receiving bond treatment. Proceeds from sales of bonds for the years ended December 31 are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Proceeds from sales |
| $ | 89,218 |
|
| 97,922 |
|
| 82,882 |
|
Gross gains |
| 181 |
|
| 152 |
|
| 82 |
|
Gross losses |
| 1,837 |
|
| 335 |
|
| 80 |
|
For the years ended December 31, 2023 and 2022, there were 1 and 13 CUSIPs sold, disposed, or otherwise redeemed as a result of a callable feature, respectively. The aggregate amount of investment income generated as a result of these transactions was $0 and $642 for 2023 and 2022, respectively.
The Company’s bond portfolio includes mortgage-backed securities. Due to the high quality of these investments and the lack of subprime loans within the securities, the Company does not have a material exposure to subprime mortgages.
(b) Unrealized Investment Losses
To determine whether or not declines in fair value are other than temporary, Allianz Life performs a quarterly review of its entire combined investment portfolio, including the Company as their subsidiary, using quoted market prices by third-party sources. For further discussion, see Notes 2 and 6.
Unrealized losses and the related fair value of investments held by the Company for the years ended December 31 are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 12 months or less |
| Greater than 12 months |
| Total |
| Fair value |
| Unrealized losses |
| Fair value |
| Unrealized losses |
| Fair value |
| Unrealized losses |
Bonds: |
|
|
|
|
|
|
|
|
|
|
|
U.S. government | $ | — |
|
| — |
|
| 134,421 |
|
| 8,161 |
|
| 134,421 |
|
| 8,161 |
|
States and political subdivisions | 1,881 |
|
| 54 |
|
| 5,220 |
|
| 623 |
|
| 7,101 |
|
| 677 |
|
Corporate securities | 15,227 |
|
| 360 |
|
| 213,090 |
|
| 27,040 |
|
| 228,317 |
|
| 27,400 |
|
Mortgage-backed securities | 606 |
|
| 5 |
|
| 89,360 |
|
| 8,632 |
|
| 89,966 |
|
| 8,637 |
|
Total temporarily impaired securities | $ | 17,714 |
|
| 419 |
|
| 442,091 |
|
| 44,456 |
|
| 459,805 |
|
| 44,875 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
| 12 months or less |
| Greater than 12 months |
| Total |
| Fair value |
| Unrealized losses |
| Fair value |
| Unrealized losses |
| Fair value |
| Unrealized losses |
Bonds: |
|
|
|
|
|
|
|
|
|
|
|
U.S. government | $ | 149,836 |
|
| 7,654 |
|
| 30,896 |
|
| 4,346 |
|
| 180,732 |
|
| 12,000 |
|
States and political subdivisions | 5,088 |
|
| 776 |
|
| — |
|
| — |
|
| 5,088 |
|
| 776 |
|
Corporate securities | 197,026 |
|
| 22,189 |
|
| 56,543 |
|
| 15,731 |
|
| 253,569 |
|
| 37,920 |
|
Mortgage-backed securities | 78,483 |
|
| 5,516 |
|
| 17,776 |
|
| 5,191 |
|
| 96,259 |
|
| 10,707 |
|
Total temporarily impaired securities | $ | 430,433 |
|
| 36,135 |
|
| 105,215 |
|
| 25,268 |
|
| 535,648 |
|
| 61,403 |
|
As of December 31, 2023 and 2022, the number of bonds that were in an unrealized loss position was 200 and 225, respectively.
As of December 31, 2023 and 2022, of the total amount of unrealized losses, $44,672, or 99.5%, and $61,245, or 99.7%, respectively, are related to unrealized losses on investment grade securities. Investment grade is defined as a security having an NAIC SVO credit rating of 1 or 2. Unrealized losses on securities are principally related to changes in interest rates or changes in sector spreads from the date of purchase. As contractual payments continue to be met, management continues to expect all contractual cash flows to be received and does not consider these investments to be other-than-temporarily impaired.
(c) Realized Investment Gains (Losses)
Net realized capital gains (losses) for the years ended December 31 are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Bonds |
| $ | (1,912) |
|
| (722) |
|
| 2 |
|
Derivatives |
| (41,041) |
|
| 23,057 |
|
| (60,008) |
|
Other |
| 5 |
|
| (25) |
|
| 64 |
|
Total realized capital (losses) gains |
| (42,948) |
|
| 22,310 |
|
| (59,942) |
|
Income tax benefit (expense) on net realized gains (losses) |
| 450 |
|
| 38 |
|
| (20) |
|
Total realized capital (losses) gains, net of taxes |
| (42,498) |
|
| 22,348 |
|
| (59,962) |
|
Net (losses) gains transferred to IMR, net of taxes |
| (1,341) |
|
| (290) |
|
| (5) |
|
Net realized (losses) gains, net of taxes and IMR |
| $ | (41,157) |
|
| 22,638 |
|
| (59,957) |
|
(d) Net Investment Income
Major categories of net investment income for the years ended December 31 are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Interest: |
|
|
|
|
|
|
Bonds |
| 21,130 |
|
| 20,464 |
|
| 19,345 |
|
Policy loans |
| 11 |
|
| 8 |
|
| 7 |
|
Cash, cash equivalents, and short-term investments |
| 3,085 |
|
| 553 |
|
| 2 |
|
Derivatives |
| — |
|
| — |
|
| (1) |
|
Other |
| 96 |
|
| 72 |
|
| 119 |
|
Gross investment income |
| 24,322 |
|
| 21,097 |
|
| 19,472 |
|
Investment expenses |
| (1,532) |
|
| (971) |
|
| (1,579) |
|
Net investment income before amortization of IMR |
| 22,790 |
|
| 20,126 |
|
| 17,893 |
|
Amortization of IMR |
| (2,759) |
|
| (2,026) |
|
| (1,716) |
|
Net investment income |
| $ | 20,031 |
|
| 18,100 |
|
| 16,177 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
Interest income due and accrued for the years ended December 31 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
Gross | $ | 5,071 |
|
| 4,719 |
|
Nonadmitted | — |
|
| — |
|
Admitted | $ | 5,071 |
|
| 4,719 |
|
The Company had no aggregate deferred interest as of December 31, 2023 and 2022.
The Company had no cumulative amounts of paid-in-kind interest included in the current principal balance as of December 31, 2023 and 2022.
(e) Loan-Backed Securities
SSAP No. 43R requires the bifurcation of impairment losses on loan-backed or structured securities into interest and noninterest-related portions. The noninterest portion is the difference between the present value of cash flows expected to be collected from the security and the amortized cost basis of the security. The interest portion is the difference between the present value of cash flows expected to be collected from the security and its fair value at the balance sheet date.
The Company had no loan-backed securities with a recognized OTTI for the years ended December 31, 2023 and 2022.
(f) Derivatives and Hedging Instruments
The Company does not have derivative contracts with financing premium. Derivatives held by the Company do not qualify for hedge accounting treatment.
Futures and Options Contracts
OTC options are cleared through the Options Clearing Corporation, which operates under the jurisdiction of both the Securities and Exchange Commission (SEC) and the Commodities Futures Trading Commission. The fair values of the collateral posted for futures and OTC options are discussed in the derivative collateral management section below.
The following table presents a summary of the aggregate notional amounts and fair values of the Company’s derivative instruments reported on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus as of December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
|
|
|
| Gross Fair Value |
|
|
| Gross Fair Value |
|
| Notional (1) |
| Assets |
| Liabilities |
| Notional (1) |
| Assets |
| Liabilities |
OTC options |
| $ | 111 |
|
| 26 |
|
| — |
|
| — |
|
| — |
|
| — |
|
| | | | | | | | | | | | |
Futures |
| 336,455 |
|
| — |
|
| — |
|
| 302,305 |
|
| — |
|
| — |
|
| | | | | | | | | | | | |
Total derivative instruments |
|
|
| $ | 26 |
|
| — |
|
|
|
| — |
|
| — |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Notional amounts are presented on an absolute basis. |
Derivative Collateral Management
The Company manages derivative collateral for the general account and separate account combined. Additionally, said derivative collateral is managed separately between exchange-traded and OTC derivatives. The total collateral posted for exchange-traded derivatives at December 31, 2023 and 2022, had a fair value of $45,086 and $26,302, respectively, and is included in Bonds on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus and recorded at amortized cost. The Company retains ownership of the exchange-traded collateral, but the collateral resides in an account designated by the exchange. The collateral is subject to specific exchange rules regarding rehypothecation.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(g) Offsetting Assets and Liabilities
The Company elects to disclose derivative assets and liabilities eligible for offset under SSAP No. 64 – Offsetting and Netting of Assets and Liabilities on a gross basis on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus in accordance with the provisions set forth in SSAP No. 86. This treatment is consistent with the Company’s historical reporting presentation.
(h) Restricted Assets
As of December 31, 2023, the Company had the following restricted assets, including assets pledged to others as collateral, recorded at book value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross Restricted |
|
|
|
|
| Percentage |
|
| Total general account |
| Total separate account |
| Total current year |
| Total prior year |
| Increase (decrease) |
| Total current year admitted restricted |
| Gross restricted to total assets |
| Admitted restricted to total admitted assets |
On deposit with states |
| $ | 1,662 |
|
| — |
|
| 1,662 |
|
| 1,651 |
|
| 11 |
|
| 1,662 |
|
| — | % |
| — | % |
Derivative collateral |
| 50,136 |
|
| — |
|
| 50,136 |
|
| 48,894 |
|
| 1,242 |
|
| 50,136 |
|
| 0.8 |
|
| 0.8 |
|
Total restricted assets |
| 51,798 |
|
| — |
|
| 51,798 |
|
| 50,545 |
|
| 1,253 |
|
| 51,798 |
|
| 0.8 | % |
| 0.8 | % |
(i) Negative IMR
Fixed income investments generating IMR losses comply with the the Company’s documented investment and liability management policies. IMR losses for fixed-income-related derivatives are all in accordance with prudent and documented risk management procedures, in accordance with the Company’s derivative use plans and reflect symmetry with historical treatment in which unrealized derivative gains were reversed to IMR and amortized in lieu of being recognized as realized gains upon derivative termination. Asset sales that generated admitted negative IMR were not compelled by liquidity pressures.
As of December 31, 2023, the Company had the following net negative IMR and admitted negative IMR balances:
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| General Account | Insulated Separate Account | Non-Insulated Separate Account |
Net Negative IMR | $ | (11,618) |
| — |
| (4,669) |
|
Admitted Negative IMR | 11,618 |
| — |
| 4,290 |
|
Calculated Adjusted Capital and Surplus | 159,072 |
Percentage of Admitted Negative IMR to Adjusted Capital | 7.3 | % | — | % | 2.7 | % |
As of December 31, 2022, the Company had no admitted negative IMR balances.
As of December 31, 2023, the Company had the following unamortized balances in IMR from the allocation of gains/losses from derivatives that were reported at fair value prior to the termination of the derivative:
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| General Account | Insulated Separate Account | Non-Insulated Separate Account |
Unamortized gains | $ | 32,780 |
| — |
| — |
|
Unamortized losses | (19,718) |
| — |
| — |
|
There were no unamortized balances in IMR as of December 31, 2022.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(6) Fair Value Measurements
SSAP No. 100R – Fair Value establishes a fair value hierarchy that prioritizes the inputs used in the valuation techniques to measure fair value.
Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date.
Level 2 – Valuations derived from techniques that utilize observable inputs, other than quoted prices included in Level 1, which are observable for the asset or liability either directly or indirectly, such as:
(a) Quoted prices for similar assets or liabilities in active markets.
(b) Quoted prices for identical or similar assets or liabilities in markets that are not active.
(c) Inputs other than quoted prices that are observable.
(d) Inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 – Valuations derived from techniques in which the significant inputs are unobservable. Level 3 fair values reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).
The Company has analyzed the valuation techniques and related inputs, evaluated its assets and liabilities reported at fair value, and determined an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Based on the results of this evaluation and investment class analysis, each financial asset and liability was classified into Level 1, 2, or 3.
The following presents the assets and liabilities measured at fair value on a recurring basis and their corresponding level in the fair value hierarchy at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
| Level 1 |
| Level 2 (a) |
| Level 3 |
| Total |
Assets at fair value |
|
|
|
|
|
|
|
|
Derivative assets |
| $ | — |
|
| 26 |
|
| — |
|
| 26 |
|
Separate account assets |
| $ | 1,945,422 |
|
| 459,996 |
|
| — |
|
| 2,405,418 |
|
Total assets reported at fair value |
| 1,945,422 |
|
| 460,022 |
|
| — |
|
| 2,405,444 |
|
Liabilities at fair value |
|
|
|
|
|
|
|
|
| | | | | | | | |
Separate account derivative liabilities |
| — |
|
| 174,717 |
|
| — |
|
| 174,717 |
|
Total liabilities reported at fair value |
| $ | — |
|
| 174,717 |
|
| — |
|
| 174,717 |
|
|
|
|
|
|
|
|
|
|
(a) The Company does not have any assets or liabilities measured at net asset value (NAV) that are included in Level 2 within this table. |
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
| Level 1 |
| Level 2 (a) |
| Level 3 |
| Total |
Assets at fair value |
|
|
|
|
|
|
|
|
Derivative assets |
| $ | — |
|
| — |
|
| — |
|
| — |
|
Separate account assets |
| 1,958,660 |
|
| 113,012 |
|
| — |
|
| 2,071,672 |
|
Total assets reported at fair value |
| 1,958,660 |
|
| 113,012 |
|
| — |
|
| 2,071,672 |
|
Liabilities at fair value |
|
|
|
|
|
|
|
|
Separate account derivative liabilities |
| — |
|
| 122,296 |
|
| — |
|
| 122,296 |
|
Total liabilities reported at fair value |
| $ | — |
|
| 122,296 |
|
| — |
|
| 122,296 |
|
|
|
|
|
|
|
|
|
|
(a) The Company does not have any assets or liabilities measured at NAV that are included in Level 2 within this table. |
The following is a discussion of the methodologies used to determine fair values for the assets and liabilities listed in the above table. These fair values represent an exit price (i.e., what a buyer in the marketplace would pay for an asset in a current sale or charge to transfer a liability). The Company has not made changes to valuation techniques in 2023.
(a) Valuation of Derivatives
The fair value of OTC option assets and liabilities are derived internally, by calculating their expected discounted cash flows, using a set of calibrated, risk-neutral stochastic scenarios, including a market data monitor, a market data model generator, a stochastic scenario calibrator, and the actual asset pricing calculator, because active markets do not exist. Options that are internally priced and IRS, foreign currency swaps, TBA securities, and CDS are included in Level 2, because they use market observable inputs. The fair values of exchange-traded options and futures contracts are based on quoted market prices in active markets and are included in Level 1.
Certain derivatives are priced using external third-party vendors. The Company has controls in place to monitor the valuations of these derivatives. These prices are also internally recalculated and reviewed for reasonableness at the position level on a monthly basis. The Company does not have insight into the specific inputs used by third-party vendors; however, the key unobservable input would generally include the spread.
(b) Valuation of Separate Account Assets and Separate Account Derivative Liabilities
Separate account assets and Separate account derivative liabilities, with the exception of certain bonds, cash, cash equivalents and investment income due and accrued, are carried at fair value, which is based on the fair value of the underlying assets which are described throughout this note. Funds in the separate accounts are primarily invested in variable investment option funds with the following investment types: bond, domestic equity, international equity, or specialty. Variable investment option funds are included in Level 1 because their fair value is based on quoted prices in active, observable markets. The remaining investments are categorized similar to the investments held by the Company in the general account (e.g., if the separate account invested in bonds, short-term investments and derivatives, that portion could be classified within Level 2 or Level 3). Certain bonds, cash and cash equivalents, along with related accrued investment income and receivables, carried at amortized cost within the separate account have an amortized cost of $2,973,744 and $2,275,854 as of December 31, 2023 and 2022, respectively, and a fair value of $2,778,435 and $1,956,071 as of December 31, 2023 and 2022, respectively. Separate account assets carried at amortized cost are included in the table in section 6(f) below.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(c) Level 3 Rollforward
The Company did not have any Level 3 assets or liabilities during the year ended December 31, 2023.
The following table provides a reconciliation of the beginning and ending balances for the Company’s Level 3 assets and liabilities measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| January 1, 2022 | Transfers into Level 3 | Transfers out of Level 3 | Total gains and (losses) included in Net Income | Total gains and (losses) included in Surplus | Purchases, issuances, sales and settlements | December 31, 2022 |
|
|
|
|
|
|
|
|
TRS asset | $ | — |
| — |
| — |
| — |
| — |
| — |
| — |
|
Total Level 3 assets | — |
| — |
| — |
| — |
| — |
| — |
| — |
|
|
|
|
|
|
|
|
|
TRS liability | — |
| — |
| — |
| (758) |
| — |
| 758 |
| — |
|
Total Level 3 liabilities | $ | — |
| — |
| — |
| (758) |
| — |
| 758 |
| — |
|
(d) Transfers
The Company reviews its fair value hierarchy classifications quarterly. Transfers between levels occur when there are changes in the observability of inputs and market activity.
For the years ended December 31, 2023 and 2022, the Company did not have any transfers into or out of Level 3.
(e) Estimates
The Company has been able to estimate the fair value of all financial assets and liabilities.
(f) Aggregate Fair Value of Financial Instruments
The following tables present the carrying amounts and fair values of all financial instruments at December 31 (b):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
| Fair Value |
|
| Aggregate Fair Value |
| Admitted Assets/ Carrying Value |
| Level 1 |
| Level 2 |
| Level 3 |
Financial Assets |
|
|
|
|
|
|
|
|
|
|
Bonds |
| $ | 580,288 |
|
| 618,672 |
|
| 134,421 |
|
| 443,089 |
|
| 2,778 |
|
| | | | | | | | | | |
Cash equivalents |
| 47,759 |
|
| 47,759 |
|
| 47,759 |
|
| — |
|
| — |
|
| | | | | | | | | | |
Derivative assets |
| 26 |
|
| 26 |
|
| — |
|
| 26 |
|
| — |
|
Separate account assets |
| 5,199,897 |
|
| 5,399,495 |
|
| 2,014,610 |
|
| 3,171,611 |
|
| 13,676 |
|
Financial Liabilities |
|
|
|
|
|
|
|
|
|
|
Deposit-type contracts |
| $ | 6,651 |
|
| 6,478 |
|
| — |
|
| — |
|
| 6,651 |
|
Other investment contracts |
| 247,134 |
|
| 397,007 |
|
| — |
|
| — |
|
| 247,134 |
|
| | | | | | | | | | |
Separate account liabilities |
| 5,199,897 |
|
| 5,399,495 |
|
| 2,014,610 |
|
| 3,171,611 |
|
| 13,676 |
|
|
|
|
|
|
|
|
|
|
|
|
(b) The Company does not have any assets or liabilities measured at NAV that are included in Level 2 in this table. In addition, the Company has no assets or liabilities for which it is not practicable to measure at fair value. |
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
| Fair Value |
|
| Aggregate Fair Value |
| Admitted Assets/ Carrying Value |
| Level 1 |
| Level 2 |
| Level 3 |
Financial Assets |
|
|
|
|
|
|
|
|
|
|
Bonds |
| $ | 588,527 |
|
| 647,422 |
| 180,732 |
| 407,795 |
| — |
|
| | | | | | | | | | |
Cash equivalents |
| 26,558 |
|
| 26,558 |
|
| 26,558 |
|
| — |
|
| — |
|
| | | | | | | | | | |
| | | | | | | | | | |
Separate account assets |
| 4,027,744 |
|
| 4,347,526 |
| 1,982,157 |
| 2,045,587 |
| — |
|
Financial Liabilities |
|
|
|
|
|
|
|
|
|
|
Deposit-type contracts |
| $ | 6,815 |
|
| 6,735 |
| — |
|
| — |
|
| 6,815 |
|
Other investment contracts |
| 384,701 |
|
| 434,151 |
| — |
|
| — |
|
| 384,701 |
|
Separate account liabilities |
| 4,027,744 |
|
| 4,347,526 |
| 1,982,157 |
|
| 2,045,587 |
|
| — |
|
|
|
|
|
|
|
|
|
|
|
|
(b) The Company does not have any assets or liabilities measured at NAV that are included in Level 2 in this table. In addition, the Company has no assets or liabilities for which it is not practicable to measure at fair value. |
A description of the Company’s valuation techniques for financial instruments not reported at fair value and categorized within the fair value hierarchy is shown below:
Valuation of Bonds
The fair value of bonds is based on quoted market prices in active markets when available. Based on the market data, the securities are categorized into asset class, and based on the asset class of the security, appropriate pricing applications, models and related methodology, and standard inputs are utilized to determine what a buyer in the marketplace would pay for the security in a current sale. When quoted prices are not readily available or in an inactive market, standard inputs used in the valuation models, listed in approximate order of priority, include, but are not limited to, benchmark yields, reported trades, Municipal Securities Rulemaking Board reported trades, Nationally Recognized Municipal Securities Information Repository material event notices, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic events. In some cases, including private placement securities and certain difficult-to-price securities, internal pricing models may be used that are based on market proxies. Internal pricing models based on market spread and U.S. Treasury rates are used to value private placement holdings. The primarily unobservable input used in the discounted cash flow models for states and political subdivisions, foreign government, and corporate bonds is a corporate index option adjusted spread (OAS). CDO and certain mortgage-backed securities are priced by a third-party vendor and the Company internally reviews the valuation for reasonableness. The Company does not have insight into the specific inputs; however, the key unobservable inputs would generally include default rates.
Generally, U.S. Treasury securities and exchange-traded stocks are included in Level 1. Most bonds for which prices are provided by third-party pricing sources are included in Level 2, because the inputs used are market observable. Bonds for which prices were obtained from broker quotes, certain bonds without active trading markets and private placement securities that are internally priced are included in Level 3.
Valuation of Cash Equivalents
Cash equivalents are comprised of money market mutual funds. The fair value of money market mutual funds is based on quoted market prices in active markets and included in Level 1.
Valuation of Deposit-Type Contracts
Fair values of deposit-type contracts are based on discounted cash flows using internal inputs, including the discount rate and consideration of the Company’s own credit standing and a risk margin for actuarial inputs.
Valuation of Other Investment Contracts
Other investment contracts are included within Life policies and annuity contracts within the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Other investment contracts include certain reserves related to deferred annuities and other payout annuities that may include life contingencies, but do not
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
have significant mortality risk due to substantial periods certain. Fair values are based on discounted cash flows using internal inputs, including the discount rate and consideration of the Company’s own credit standing and a risk margin for market inputs.
Valuation of Separate Account Liabilities
The fair value of separate account liabilities approximates the fair value of separate account assets.
(7) Income Taxes
(a) Deferred Tax Assets and Liabilities
The components of the net DTA or net DTL are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2023 |
| Ordinary |
| Capital |
| Total |
Total gross deferred tax assets | $ | 29,751 |
|
| 756 |
|
| 30,507 |
|
Statutory valuation allowance adjustments | — |
|
| — |
|
| — |
|
Adjusted gross deferred tax assets | 29,751 |
|
| 756 |
|
| 30,507 |
|
Deferred tax assets nonadmitted | (19,096) |
|
|
|
| (19,096) |
|
Subtotal net admitted deferred tax assets | 10,655 |
|
| 756 |
|
| 11,411 |
|
Deferred tax liabilities | (1,190) |
|
| — |
|
| (1,190) |
|
Net admitted deferred tax assets | $ | 9,465 |
|
| 756 |
|
| 10,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2022 |
| Ordinary |
| Capital |
| Total |
Total gross deferred tax assets | $ | 27,191 |
|
| 814 |
|
| 28,005 |
|
Statutory valuation allowance adjustments | — |
|
| — |
|
| — |
|
Adjusted gross deferred tax assets | 27,191 |
|
| 814 |
|
| 28,005 |
|
Deferred tax assets nonadmitted | (17,639) |
|
| — |
|
| (17,639) |
|
Subtotal net admitted deferred tax assets | 9,552 |
|
| 814 |
|
| 10,366 |
|
Deferred tax liabilities | (1,927) |
|
| — |
|
| (1,927) |
|
Net admitted deferred tax assets | $ | 7,625 |
|
| 814 |
|
| 8,439 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change |
| Ordinary |
| Capital |
| Total |
Total gross deferred tax assets | $ | 2,560 |
|
| (58) |
|
| 2,502 |
|
Statutory valuation allowance adjustments | — |
|
| — |
|
| — |
|
Adjusted gross deferred tax assets | 2,560 |
|
| (58) |
|
| 2,502 |
|
Deferred tax assets nonadmitted | (1,457) |
|
| — |
|
| (1,457) |
|
Subtotal net admitted deferred tax assets | 1,103 |
|
| (58) |
|
| 1,045 |
|
Deferred tax liabilities | 737 |
|
| — |
|
| 737 |
|
Net admitted deferred tax assets | $ | 1,840 |
|
| (58) |
|
| 1,782 |
|
The amount of admitted adjusted gross DTAs allowed under each component of SSAP No. 101 – Income Taxes (SSAP No. 101) as of December 31 are as follows:
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2023 |
| Ordinary |
| Capital |
| Total |
Federal income taxes paid in prior years recoverable through loss carrybacks (11.a) | $ | — |
|
| — |
|
| — |
|
Adjusted gross DTAs expected to be realized after application of the threshold limitations |
|
|
|
|
|
Lesser of 11.b.i or 11.b.ii: |
|
|
|
|
|
Adjusted gross DTAs expected to be realized following the balance sheet date (11.b.i.) | 9,465 |
|
| 756 |
|
| 10,221 |
|
Adjusted gross DTAs allowed per limitation threshold (11.b.ii) | N/A |
| N/A |
| 24,504 |
|
Lesser of 11.b.i or 11.b.ii | 9,465 |
|
| 756 |
|
| 10,221 |
|
Adjusted gross DTAs offset by gross DTLs (11.c) | 1,190 |
|
| — |
|
| 1,190 |
|
Deferred tax assets admitted | $ | 10,655 |
|
| 756 |
|
| 11,411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2022 |
| Ordinary |
| Capital |
| Total |
Federal income taxes paid in prior years recoverable through loss carrybacks (11.a) | $ | — |
|
| 718 |
|
| 718 |
|
Adjusted gross DTAs expected to be realized after application of the threshold limitations |
|
|
|
|
|
Lesser of 11.b.i or 11.b.ii: |
|
|
|
|
|
Adjusted gross DTAs expected to be realized following the balance sheet date (11.b.i.) | 7,625 |
|
| 96 |
|
| 7,721 |
|
Adjusted gross DTAs allowed per limitation threshold (11.b.ii) | N/A |
| N/A |
| 24,469 |
|
Lesser of 11.b.i or 11.b.ii | 7,625 |
|
| 96 |
|
| 7,721 |
|
Adjusted gross DTAs offset by gross DTLs (11.c) | 1,927 |
|
| — |
|
| 1,927 |
|
Deferred tax assets admitted | $ | 9,552 |
|
| 814 |
|
| 10,366 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change |
| Ordinary |
| Capital |
| Total |
Federal income taxes paid in prior years recoverable through loss carrybacks (11.a) | $ | — |
|
| (718) |
|
| (718) |
|
Adjusted gross DTAs expected to be realized after application of the threshold limitations |
|
|
|
|
|
Lesser of 11.b.i or 11.b.ii: |
|
|
|
|
|
Adjusted gross DTAs expected to be realized following the balance sheet date (11.b.i.) | 1,840 |
|
| 660 |
|
| 2,500 |
|
Adjusted gross DTAs allowed per limitation threshold (11.b.ii) | N/A |
| N/A |
| 35 |
|
Lesser of 11.b.i or 11.b.ii | 1,840 |
|
| 660 |
|
| 2,500 |
|
Adjusted gross DTAs offset by gross DTLs (11.c) | (737) |
|
| — |
|
| (737) |
|
Deferred tax assets admitted | $ | 1,103 |
|
| (58) |
|
| 1,045 |
|
Ratios used for threshold limitation as of December 31 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31 |
|
|
| 2023 |
| 2022 |
| Change |
Ratio percentage used to determine recovery period and threshold limitation amount | 552 | % |
| 589 | % |
| (37) | % |
Amount of adjusted capital and surplus used to determine recovery period threshold limitation | $ | 163,362 |
|
| $ | 163,125 |
|
| $ | 237 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
Impact of tax planning strategies on the determination of net admitted adjusted gross DTAs is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2023 |
| Ordinary |
| Capital |
| Total |
Net admitted adjusted gross DTAs - (percentage of total net admitted adjusted gross DTAs) | — | % |
| 100.0 | % |
| 100.0 | % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2022 |
| Ordinary |
| Capital |
| Total |
Net admitted adjusted gross DTAs - (percentage of total net admitted adjusted gross DTAs) | — | % |
| 11.8 | % |
| 11.8 | % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change |
| Ordinary |
| Capital |
| Total |
Net admitted adjusted gross DTAs - (percentage of total net admitted adjusted gross DTAs) | — | % |
| 88.2 | % |
| 88.2 | % |
The Company’s tax planning strategies do not include the use of reinsurance.
(b) Unrecognized Deferred Tax Liabilities
There are no temporary differences for which DTLs are not recognized.
(c) Current and Deferred Income Taxes
The significant components of income taxes incurred (i.e. Current income tax expense) include:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31 |
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
| 2023-2022 Change |
| 2022-2021 Change |
Current year federal tax expense (benefit) - ordinary income | $ | (1,665) |
|
| 3,586 |
|
| 6,319 |
|
| (5,251) |
|
| (2,733) |
|
Current year foreign tax expense (benefit) - ordinary income | — |
|
| — |
|
| — |
|
| — |
|
| — |
|
Subtotal | (1,665) |
|
| 3,586 |
|
| 6,319 |
|
| (5,251) |
|
| (2,733) |
|
Current year tax expense (benefit) - net realized capital gains (losses) | (450) |
|
| (38) |
|
| 19 |
|
| (412) |
|
| (57) |
|
Federal and foreign income taxes incurred | $ | (2,115) |
|
| 3,548 |
|
| 6,338 |
|
| (5,663) |
|
| (2,790) |
|
DTAs and DTLs consist of the following major components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31 |
|
|
Deferred tax assets |
| 2023 |
| 2022 |
| Change |
Ordinary: |
|
|
|
|
|
|
Deferred acquisition costs |
| $ | 5,054 |
|
| 4,241 |
|
| 813 |
|
Policyholder reserves |
| 22,957 |
|
| 22,937 |
|
| 20 |
|
Expense accruals |
| 1 |
|
| 7 |
|
| (6) |
|
Investments |
| 1,732 |
|
| — |
|
| 1,732 |
|
Nonadmitted assets |
| 7 |
|
| 6 |
|
| 1 |
|
Subtotal |
| 29,751 |
|
| 27,191 |
|
| 2,560 |
|
| | | | | | |
Nonadmitted ordinary deferred tax assets |
| (19,096) |
|
| (17,639) |
|
| (1,457) |
|
Admitted ordinary tax assets |
| 10,655 |
|
| 9,552 |
|
| 1,103 |
|
|
|
|
|
|
| — |
|
Capital: |
|
|
|
|
| — |
|
Impaired assets |
| 756 |
|
| 814 |
|
| (58) |
|
Subtotal |
| 756 |
|
| 814 |
|
| (58) |
|
| | | | | | |
| | | | | | |
Admitted capital deferred tax assets |
| 756 |
|
| 814 |
|
| (58) |
|
Admitted deferred tax assets |
| $ | 11,411 |
|
| 10,366 |
|
| 1,045 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31 |
|
|
Deferred tax liabilities |
| 2023 |
| 2022 |
| Change |
Ordinary: |
|
|
|
|
|
|
Investments |
| $ | (563) |
|
| (989) |
|
| 426 |
|
| | | | | | |
Policyholder reserves |
| (621) |
|
| (931) |
|
| 310 |
|
Deferred and uncollected premiums |
| (6) |
|
| (7) |
|
| 1 |
|
Subtotal |
| (1,190) |
|
| (1,927) |
|
| 737 |
|
|
|
|
|
|
|
|
Capital: |
|
|
|
|
|
|
Other |
| — |
|
| — |
|
| — |
|
Subtotal |
| — |
|
| — |
|
| — |
|
Deferred tax liabilities |
| (1,190) |
|
| (1,927) |
|
| 737 |
|
Net deferred tax asset |
| $ | 10,221 |
|
| 8,439 |
|
| 1,782 |
|
The realization of the DTAs is dependent upon the Company’s ability to generate sufficient taxable income in future periods. Based on historical results and the prospects for future current operations, management anticipates that it is more likely than not that future taxable income will be sufficient for the realization of the remaining DTAs.
The Inflation Reduction Act was enacted on August 16, 2022. The Company has determined as of December 31, 2023 that it is an applicable corporation with respect to the Corporate Alternative Minimum Tax ("CAMT"), but that it will not incur a CAMT liability in 2023. The financial statements, therefore, do not include any impact related to CAMT. The Company has made an accounting election to disregard CAMT when evaluating the need for a Valuation Allowance for its non-CAMT DTAs.
In computing taxable income, life insurance companies are allowed a deduction attributable to their life insurance and accident and health reserves. The Tax Act of 2017 significantly changed the methodology by which these reserves are computed for tax purposes. The changes are effective for tax years beginning after 2017 and are subject to a transition rule that spreads the additional income tax liability over the subsequent eight years beginning in 2018. Due to complexities in the new methodology and limited guidance from the Internal Revenue Service and U.S. Treasury, the Company has recorded provisional amounts for the deferred tax revaluation associated with the changes in the computation of life insurance tax reserves based on information available at December 31, 2017. Pursuant to Interpretation of the SAP Working Group 18-01: Updated Tax Estimates under the Tax Cuts and Jobs Act, provisional tax computations related to these amounts were reasonably estimated as of December 31, 2017 and have been adjusted based on guidance received from Internal Revenue Service and U.S. Treasury. Adjusted amounts are reflected in the Company's results of operations for the years ended December 31, 2023, 2022, and 2021.
The Change in net deferred income tax is comprised of the following (this analysis is exclusive of the nonadmitted DTAs as the Change in nonadmitted assets is reported separately from the Change in net deferred income tax in the Unassigned surplus section of the Statutory Statements of Capital and Surplus):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31 |
|
|
| 2023 |
| 2022 |
| Change |
Net deferred tax assets | $ | 29,316 |
|
| 26,078 |
|
| 3,238 |
|
Statutory valuation allowance adjustment | — |
|
| — |
|
| — |
|
Net deferred tax assets after statutory valuation allowance | 29,316 |
|
| 26,078 |
|
| 3,238 |
|
Tax effect of unrealized gains/(losses) | (1,732) |
|
| 626 |
|
| (2,358) |
|
| | | | | |
Change in net deferred income tax |
|
|
|
| $ | 880 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(d) Reconciliation of Federal Income Tax Rate to Actual Effective Rate
The provision for federal income taxes incurred is different from that which would be obtained by applying the statutory federal income tax rate to income before income taxes. The significant items causing this difference are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 31, 2023 |
| December 31, 2022 |
| December 31, 2021 |
Federal income tax rate | 21.0 | % |
| 21.0 | % |
| 21.0 | % |
Amortization of IMR | 2.1 |
|
| (0.9) |
|
| 0.5 |
|
Dividends received deduction | (1.6) |
|
| 1.0 |
|
| (0.8) |
|
Tax hedges | 0.9 |
|
| — |
|
| (0.2) |
|
Tax hedge reclassification | (31.3) |
|
| (10.3) |
|
| (17.5) |
|
Non-deductible expenses | 0.8 |
|
| — |
|
| — |
|
| | | | | |
Prior period adjustments | 0.4 |
|
| — |
|
| 0.5 |
|
Change in deferred tax impairments | 0.2 |
|
| 0.3 |
|
| — |
|
| | | | | |
| | | | | |
| | | | | |
Realized capital gains tax | (1.6) |
|
| 0.1 |
|
| — |
|
Correction of error surplus | (1.7) |
|
| — |
|
| — |
|
Effective tax rate | (10.8) | % |
| 11.2 | % |
| 3.5 | % |
|
|
|
|
|
|
Federal and foreign income taxes incurred | (6.0) | % |
| (7.6) | % |
| 8.8 | % |
Realized capital gains tax | (1.6) |
|
| 0.1 |
|
| — |
|
Change in net deferred income taxes | (3.2) |
|
| 18.7 |
|
| (5.3) |
|
Effective tax rate | (10.8) | % |
| 11.2 | % |
| 3.5 | % |
(e) Carryforwards, Recoverable Taxes, and IRC Section 6603 Deposits
As of December 31, 2023, there are no operating losses or tax credit carryforwards available for tax purposes.
There are no Federal income taxes available for recoupment in the event of future net losses.
There are no aggregate deposits admitted under Section 6603 of the IRC.
The Company had no tax contingencies computed in accordance with SSAP No. 101 as of December 31, 2023 and 2022.
The Company recognizes interest and penalties accrued related to unrecognized tax benefits in federal income tax expense. During the years ended December 31, 2023 and 2022, the Company recognized no such expenses.
(f) Consolidated Federal Income Tax Return
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
The Company's federal income tax return is consolidated with its parent, Allianz Life Insurance Company of North America (Allianz Life) for consolidation with the tax return of Allianz of America (AZOA), the parent of Allianz Life. The method of allocation among companies is subject to a written agreement with AZOA, approved by the Board of Directors of AZOA, that provides for computation of federal income taxes primarily on a separate company basis with the Company receiving reimbursement by AZOA for the benefit of all tax attributes, including credits and losses, when such attributes are utilized in the AZOA consolidated federal income tax return. In 2023, the Company amended the agreement to include the corporate alternative minimum tax applying principles described above. Intercompany tax balances are settled annually after the consolidated return is filed.
The Company is included in the consolidated group for which AZOA files a federal income tax return on behalf of all group members. As a member of the AZOA consolidated group, the Company is no longer subject to U.S. Federal and non-U.S. income tax examinations for years prior to 2016, though examinations of combined returns filed by AZOA, which include the Company, by certain U.S. state and local tax authorities, may still be conducted for 2016 and subsequent years. The Internal Revenue Service (IRS) examination of AZOA for the 2016 and 2017 income tax returns has completed the exam phase and has been assigned to Appeals for an issue unrelated to the Company. A verbal agreement for the settlement of this hedging issue has been reached with the IRS. The settlement is subject to a final closing agreement. The IRS has also initiated an examination of AZOA's 2018-2020 income tax returns, which is expected to close by the end of 2024.
As of December 31, 2023, the companies included in the consolidated group for which AZOA files a federal income tax return are included below:
|
|
|
|
|
|
Members of Consolidated Tax Group |
Allianz Life Insurance Company of New York | Allianz Life Insurance Company of Missouri |
Allianz Life Insurance Company of North America | Allianz Underwriters Insurance Company |
AZOA Services Corporation | AGCS Marine Insurance Company |
Allianz Global Risks US Insurance Company | Allianz Reinsurance Management Services, Inc. |
Allianz Reinsurance of America, Inc. | Fireman’s Fund Insurance Company |
Allianz Technology of America, Inc. | Fireman’s Fund Indemnity Corporation |
Allianz Renewable Energy Partners of America LLC | National Surety Corporation |
Allianz Renewable Energy Partners of America 2 LLC | Chicago Insurance Company |
PFP Holdings, LLC. | Interstate Fire & Casualty Company |
AZL PF Investments, Inc. | American Automobile Insurance Company |
Dresdner Kleinwort Pfandbriefe Investments II, Inc. | The American Insurance Company |
Allianz Fund Investments, Inc. | Allianz Risk Transfer, Inc. |
Yorktown Financial Companies, Inc. | Allianz Risk Transfer (Bermuda), Ltd. |
Questar Capital Corporation | Questar Agency, Inc. |
(8) Accident and Health Claim Reserves
Accident and health claim reserves are based on estimates that are subject to uncertainty. Uncertainty regarding reserves of a given accident year is gradually reduced as new information emerges each succeeding year, thereby allowing more reliable reevaluations of such reserves. While management believes that reserves as of December 31, 2023, are appropriate, uncertainties in the reserving process could cause reserves to develop favorably or unfavorably in the near term as new or additional information emerges. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Movements in reserves could significantly impact the Company’s future reported earnings.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
Activity in the accident and health claim reserves is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Balance at January 1, net of reinsurance recoverables of $1,416, $1,137, and $1,079, respectively |
| $ | 10,658 |
|
| 8,074 |
|
| 7,834 |
|
Incurred related to: |
|
|
|
|
|
|
Current year |
| 3,845 |
|
| 5,182 |
|
| 2,613 |
|
Prior years |
| 16 |
|
| (113) |
|
| (433) |
|
Total incurred |
| 3,861 |
|
| 5,069 |
|
| 2,180 |
|
Paid related to: |
|
|
|
|
|
|
Current year |
| 272 |
|
| 361 |
|
| 154 |
|
Prior years |
| 2,844 |
|
| 2,124 |
|
| 1,786 |
|
Total paid |
| 3,116 |
|
| 2,485 |
|
| 1,940 |
|
Balance at December 31, net of reinsurance recoverables of $1,512, $1,416, and $1,137, respectively |
| $ | 11,403 |
|
| 10,658 |
|
| 8,074 |
|
Prior year incurred claim reserves for 2023 were unfavorable as a result of re-estimation of unpaid claims and claim adjustment expenses, principally on the individual LTC line of business. Prior year incurred claim reserves for 2022 and 2021 reflect favorable claim development principally on the individual LTC line of business.
(9) Reinsurance
The Company primarily enters into reinsurance agreements to manage risk resulting from its life, annuity, and accident and health businesses, as well as businesses the Company has chosen to exit. In the normal course of business, the Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding risks under excess coverage and coinsurance contracts.
The Company monitors the financial exposure and financial strength of the reinsurers on an ongoing basis. The Company attempts to mitigate risk by securing recoverable balances with various forms of collateral, including arranging trust accounts and letters of credit with certain reinsurers.
The effect of reinsurance on reserves and claims, for amounts recoverable from other insurers, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the years ended December 31, |
Reduction in: |
| 2023 |
| 2022 |
Aggregate reserves |
| $ | 15,137 |
|
| 11,183 |
|
Policy and contract claims |
| 147 |
|
| 181 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
The Company assumed no business from other companies for the years ended December 31, 2023, 2022, and 2021. Life insurance, annuities, and accident and health business ceded to other companies are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended |
| Direct amount |
| Ceded to other companies |
| Net amount |
December 31, 2023 |
|
|
|
|
|
|
Life insurance in force |
| $ | 2,921,758 |
|
| 2,627,567 |
|
| 294,191 |
|
Premiums: |
|
|
|
|
|
|
Life |
| 3,661 |
|
| 3,321 |
|
| 340 |
|
Annuities |
| 967,460 |
|
| — |
|
| 967,460 |
|
Accident and health |
| 3,058 |
|
| 393 |
|
| 2,665 |
|
Total premiums |
| $ | 974,179 |
|
| 3,714 |
|
| 970,465 |
|
|
|
|
|
|
|
|
December 31, 2022 |
|
|
|
|
|
|
Life insurance in force |
| $ | 1,837,298 |
|
| 1,651,432 |
|
| 185,866 |
|
Premiums: |
|
|
|
|
|
|
Life |
| 2,286 |
|
| 2,046 |
|
| 240 |
|
Annuities |
| 653,562 |
|
| — |
|
| 653,562 |
|
Accident and health |
| 3,207 |
|
| 412 |
|
| 2,795 |
|
Total premiums |
| $ | 659,055 |
|
| 2,458 |
|
| 656,597 |
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
Life insurance in force |
| $ | 750,332 |
|
| 673,079 |
|
| 77,253 |
|
Premiums: |
|
|
|
|
|
|
Life |
| 1,171 |
|
| 1,035 |
|
| 136 |
|
Annuities |
| 685,610 |
|
| — |
|
| 685,610 |
|
Accident and health |
| 3,245 |
|
| 431 |
|
| 2,814 |
|
Total premiums |
| $ | 690,026 |
|
| 1,466 |
|
| 688,560 |
|
There are no nonaffiliated reinsurers owned in excess of 10% or controlled, either directly or indirectly, by the Company or by a representative, officer, trustee, or director of the Company.
There are no policies issued by the Company that have been reinsured with a company chartered in a country other than the United States that is owned in excess of 10% or controlled directly or indirectly by an insured, a beneficiary, a creditor, or any other person not primarily engaged in the insurance business.
The Company does not have any reinsurance agreements in effect under which the reinsurer may unilaterally cancel any reinsurance for reasons other than for nonpayment of premium or other similar credits.
The Company does not have reinsurance agreements in effect such that the amount of losses paid or accrued through the statement date may result in a payment to the reinsurer of amounts that, in aggregate and allowing for offset of mutual credits from other reinsurance agreements with the same reinsurer, exceed the total direct premium collected under the reinsured policies.
The Company did not write off any uncollectible recoverables during 2023, 2022, and 2021.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(10) Annuity Actuarial Reserves and Deposit Liabilities by Withdrawal Characteristics
Information regarding the Company’s annuity actuarial reserves and deposit liabilities by withdrawal characteristics at December 31 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| Percentage of total |
| 2022 |
| Percentage of total |
Subject to discretionary withdrawal: |
|
|
|
|
|
|
|
|
With market value adjustment |
| $ | 79,917 |
|
| 1 | % |
| $ | 82,552 |
|
| 2 | % |
At book value less current surrender charges of 5% or more |
| 2,704,747 |
|
| 49 |
|
| 1,897,657 |
|
| 41 |
|
At market value |
| 1,574,991 |
|
| 29 |
|
| 1,599,527 |
|
| 35 |
|
Total with adjustment or at market value |
| 4,359,655 |
|
| 79 |
|
| 3,579,736 |
|
| 78 |
|
At book value without adjustment (minimal or no charge or adjustment) |
| 1,044,473 |
|
| 19 |
|
| 873,856 |
|
| 19 |
|
Not subject to discretionary withdrawal |
| 121,446 |
|
| 2 |
|
| 114,825 |
|
| 3 |
|
Total gross |
| 5,525,574 |
|
| 100 | % |
| 4,568,417 |
|
| 100 | % |
Reinsurance ceded |
| — |
|
|
|
| — |
|
|
|
Total net |
| $ | 5,525,574 |
|
|
|
| $ | 4,568,417 |
|
|
|
Amount included in At book value less current charges of 5% or more that will move to At book value without adjustment in the year after the statement date: |
| $ | 447,649 |
|
|
|
| $ | 271,907 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of total annuity actuarial reserves and deposit fund liabilities: |
| 2023 |
| 2022 |
Life, Accident and Health Annual Statement: |
|
|
|
|
Annuities, net (excluding supplementary contracts with life contingencies) |
| $ | 340,007 |
|
| 377,151 |
|
Supplemental contracts with life contingencies, net |
| 23,099 |
|
| 21,956 |
|
Deposit-type contracts |
| 6,478 |
|
| 6,735 |
|
Subtotal |
| 369,584 |
|
| 405,842 |
|
Separate Accounts Annual Statement: |
|
|
|
|
Annuities, net (excluding supplementary contracts with life contingencies) |
| 5,155,534 |
|
| 4,162,122 |
|
Supplemental contracts with life contingencies, net |
| 456 |
|
| 453 |
|
Subtotal |
| 5,155,990 |
|
| 4,162,575 |
|
Total annuity actuarial reserves and deposit fund liabilities |
| $ | 5,525,574 |
|
| 4,568,417 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(11) Life Actuarial Reserves by Withdrawal Characteristics
Information regarding the Company’s life actuarial reserves by withdrawal characteristics at December 31 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
General Account | Account value | Cash value | Reserve |
Subject to discretionary withdrawal, surrender values, or policy loans: |
|
|
|
| | | |
Universal life | $ | — |
| — |
| 488 |
|
| | | |
| | | |
| | | |
Indexed life | 1,709 |
| 1,649 |
| 1,707 |
|
Other permanent cash value life insurance | 250 |
| 250 |
| 250 |
|
| | | |
| | | |
Miscellaneous reserves | — |
| — |
| 22,000 |
|
Not subject to discretionary withdrawal or no cash values: |
|
|
|
Term policies without cash value | XXX | XXX | 3,344 |
|
| | | |
| | | |
| | | |
Miscellaneous reserves | XXX | XXX | 41,114 |
|
Total gross | 1,959 |
| 1,899 |
| 68,903 |
|
Reinsurance ceded | — |
| — |
| 8,099 |
|
Total net (1) | $ | 1,959 |
| 1,899 |
| 60,804 |
|
|
|
|
|
(1) Balances reflected within this disclosure reside in the Company's general account; the Company's separate accounts do not contain Life business. |
|
|
|
|
| 2022 |
General Account | Account value | Cash value | Reserve |
Subject to discretionary withdrawal, surrender values, or policy loans: |
|
|
|
| | | |
Universal life | $ | 7 |
| 2 |
| 608 |
|
| | | |
| | | |
| | | |
Indexed life | 1,816 |
| 1,721 |
| 1,794 |
|
Other permanent cash value life insurance | 244 |
| 244 |
| 244 |
|
| | | |
| | | |
Miscellaneous reserves | — |
| — |
| 22,000 |
|
Not subject to discretionary withdrawal or no cash values: |
|
|
|
Term policies without cash value | XXX | XXX | 2,253 |
|
| | | |
| | | |
| | | |
Miscellaneous reserves | XXX | XXX | 38,185 |
|
Total gross | 2,067 |
| 1,967 |
| 65,084 |
|
Reinsurance ceded | — |
| — |
| 4,466 |
|
Total net (1) | $ | 2,067 |
| 1,967 |
| 60,618 |
|
|
|
|
|
(1) Balances reflected within this disclosure reside in the Company's general account; the Company's separate accounts do not contain Life business. |
The Company does not have any Life policies with either guarantees or nonguarantees in the separate account.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of total life actuarial reserves: | 2023 | 2022 |
Life, Accident, and Health Annual Statement: |
|
|
Life insurance, net | $ | 3,016 |
| $ | 3,112 |
|
| | |
| | |
| | |
Miscellaneous reserves, net | 57,788 |
| 57,506 |
|
| | |
| | |
| | |
| | |
Total life actuarial reserves | $ | 60,804 |
| $ | 60,618 |
|
|
|
|
|
|
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(12) Separate Accounts
The Company’s separate accounts represent funds held for the benefit of contract holders entitled to payments under variable annuity contracts issued through the Company’s separate accounts and underwritten by the Company.
As of December 31, 2023 and 2022, the Company's separate accounts are classified as nonguaranteed. Information regarding the Company’s separate accounts for the years ended December 31 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
Premiums, considerations, or deposits | $ | 884,944 |
|
| 597,807 |
|
Reserves: |
|
|
|
Reserves for accounts with assets at fair value | 2,149,845 |
|
| 1,915,239 |
|
Reserves for account, with assets at amortized cost | 3,006,145 |
|
| 2,247,336 |
|
Total reserves | 5,155,990 |
|
| 4,162,575 |
|
By withdrawal characteristics: |
|
|
|
At fair value | 2,149,388 |
|
| 1,581,648 |
|
At book value without MV adjustment and with current surrender charge of 5% or more | 2,129,600 |
|
| 1,914,787 |
|
At book value without MV adjustment and with current surrender charge of less than 5% | 876,546 |
|
| 665,687 |
|
Subtotal | 5,155,534 |
|
| 4,162,122 |
|
Not subject to discretionary withdrawal | 456 |
|
| 453 |
|
Total | $ | 5,155,990 |
|
| 4,162,575 |
|
As of December 31, 2023 and 2022, the Company’s separate accounts included legally insulated assets and non-insulated assets attributed to the following products/transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
Product/transaction |
| Legally insulated |
| Not legally insulated |
| Legally insulated |
| Not legally insulated |
Variable Annuities |
| $ | 1,591,701 |
|
| — |
|
| 1,621,829 |
|
| — |
|
Variable Annuities (Non-Unitized Non-Insulated) |
| — |
|
| 3,807,794 |
|
| — |
|
| 2,725,697 |
|
Total |
| $ | 1,591,701 |
|
| 3,807,794 |
|
| 1,621,829 |
|
| 2,725,697 |
|
The Company’s separate account liabilities contain guaranteed benefits. The liabilities for guaranteed benefits are supported by the Company’s general account assets. To compensate the general account for the risk taken, the separate account paid risk charges of $24,002, $24,891, $25,752, $26,544, and $37,538 during the past five years, respectively. The general account of the Company paid $5,133, $7,256, $191, $929, and $1,019 towards separate account guarantees during the past five years, respectively.
A reconciliation of net transfers to separate accounts for the years ended December 31 is included in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
| 2022 |
| 2021 |
Transfers as reported in the Summary of Operations of the Separate Accounts Annual Statement: |
|
|
|
|
|
|
Transfers to separate accounts |
| $ | 884,944 |
|
| 597,807 |
|
| 643,502 |
|
Transfers from separate accounts |
| (487,002) |
|
| (246,810) |
|
| (285,061) |
|
Net transfers to separate accounts |
| 397,942 |
|
| 350,997 |
|
| 358,441 |
|
Reconciling adjustments: |
|
|
|
|
|
|
Other adjustments |
| (1,373) |
|
| 289 |
|
| 97 |
|
| | | | | | |
Transfers as reported in the Statutory Statements of Operations |
| $ | 396,569 |
|
| 351,286 |
|
| 358,538 |
|
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(13) Related-Party Transactions
(a) Real Estate
The Company subleases office space from an affiliate. In connection with this agreement, the Company incurred rent expense of $83, $83, and $82 in 2023, 2022, and 2021, respectively, which is included in General and administrative expenses on the Statutory Statements of Operations.
(b) Service Fees
The Company incurred fees for administrative services provided by Allianz Life of $17,933, $17,134 and $14,025 in 2023, 2022, and 2021, respectively. The Company’s liability for these expenses was $2,854 and $1,510 as of December 31, 2023 and 2022, respectively, and is included in Payable to parent and affiliates on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. In the normal course of business, the outstanding amount is settled in cash.
The Company incurred fees for investment advisory services provided by affiliated companies of $3,747, $1,992, and $1,486 in 2023, 2022, and 2021, respectively. The Company’s liability for these charges was $407 and $232 as of December 31, 2023 and 2022, respectively, and is included in Payable to parent and affiliates on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. In the normal course of business, the outstanding amount is settled in cash.
The Company has an agreement with Allianz Investment Management, LLC which has subsequent agreements with its affiliates Pacific Investment Management Company (PIMCO), and with certain other related parties whereby (1) specific investment options managed by PIMCO are made available through the Company's separate accounts to holders of the Company's variable annuity products, and (2) the Company receives compensation for providing administrative and recordkeeping services relating to the investment options managed by PIMCO. Income recognized by the Company from this affiliate for distribution and in-force related costs as a result of providing investment options to the contractholders was $435, $575, and $729 during 2023, 2022, and 2021, respectively, which is included in Fees from separate accounts on the Statutory Statements of Operations. The related receivable for the fees was $34 and $45 at December 31, 2023 and 2022, respectively, which is included in Other assets on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
The Company has incurred commission expense related to the distribution of variable annuity products from Allianz Life Financial Services, LLC, (ALFS), an affiliated company, in the amount of $61,230, $44,736, and $46,892 for the years ended December 31, 2023, 2022, and 2021, respectively.
The Company has an agreement with ALFS, whereby 12b-1 fee receivables are assigned to the Company and Allianz Life. The Company has also agreed with Allianz Life to share in reimbursing ALFS for direct and indirect expenses incurred in performing services for the Company and Allianz Life. In the event that assigned receivables exceed expenses, ALFS records a loss on the transaction with the Company and a dividend-in-kind to Allianz Life. The Company recorded revenue from this agreement of $3,303, $3,586, and $4,261 for the years ended December 31, 2023, 2022, and 2021, respectively. The Company recorded expenses related to this agreement of $12,245, $9,234, and $8,528 for the years ended December 31, 2023, 2022, and 2021, respectively.
(c) Reinsurance
The Company cedes certain term life and universal life insurance policies to Allianz Life. At December 31, 2023 and 2022, the Company had no reinsurance recoverables and receivables from Allianz Life included in Other assets on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
(d) Line of Credit Agreement
The Company has a line of credit agreement with Allianz Life to provide liquidity as needed. The Company’s borrowing capacity under the agreement is limited to 5% of the general account admitted assets of the Company as of the preceding year end which amounts to $148,028. The Company's general account admitted assets include the book value portion of the non-insulated separate account assets. The interest rate for borrowing under the agreement is based on the Secured Overnight Financing Rate (SOFR). Borrowed amounts can be prepaid at any time with no prepayment penalty. Allianz Life provided $30,000 to the Company under the terms of this agreement on May 10, 2022 and the loan was paid in full on June 29, 2022. There was no interest accrued as of December 31, 2023 and 2022. There was no outstanding balance under the line of credit agreement as of December 31, 2023, and 2022.
(e) Dividends and Capital Contributions
The Company did not pay dividends to Allianz Life during the years ended December 31, 2023, 2022 and 2021.
The Company received capital contributions of $30,000, $30,000, and $0 from Allianz Life during the years ended December 31, 2023, 2022 and 2021, respectively.
(14) Employee Benefit Plans
The Company participates in the Allianz Asset Accumulation Plan (AAAP), a defined contribution plan sponsored by Allianz of America Corporation. Eligible employees are immediately enrolled in the AAAP on their first day of employment. The AAAP will accept participants’ pretax, Roth 401(k), and/or after-tax contributions up to 80% of the participants’ eligible compensation, although contributions remain subject to annual limitations set by the Internal Revenue Service. The Company matches up to a maximum of 7.5% of the employees’ eligible compensation. Participants are 100% vested in the Company’s matching contribution after three years of service.
The AAAP administration expenses and the trust fund, including trustee fees, investment manager fees, and audit fees, are payable from the trust fund but may, at the Company’s discretion, be paid by the Company. All legal fees are paid by the Company. It is the Company’s policy to fund the AAAP costs as incurred. The Company has expensed $395, $419, and $328 in 2023, 2022, and 2021, respectively, toward the AAAP matching contributions and administration expenses.
(15) Statutory Capital and Surplus
Statutory accounting practices prescribed or permitted by the Company’s state of domicile are directed toward insurer solvency and protection of policyholders. As such, the Company is required to meet minimum statutory capital and surplus requirements. The Company’s statutory capital and surplus as of December 31, 2023 and 2022 were in compliance with these requirements. The maximum amount of dividends that can be paid by New York insurance companies to stockholders without prior approval of the Department is subject to restrictions relating to statutory earned surplus, also known as unassigned funds. Unassigned funds are determined in accordance with the accounting procedures and practices governing preparation of the statutory annual statement. In accordance with New York statutes, the Company may declare and pay from its Unassigned surplus cash dividends of not more than the lesser of 10% of its beginning-of-the year statutory surplus, or its net gain from operations before net realized capital gains of the insurer for the 12-month period ending the 31st day of the preceding year. Based on these restrictions, ordinary dividends of $18,520 can be paid in 2024 without prior approval of the Department. The Company paid no dividends in 2023, 2022, and 2021.
The Company has special surplus funds at December 31, 2023, of $11,618, which is due to admitted disallowed IMR. Refer to Note 5(i) regarding the admitted disallowed IMR.
Regulatory Risk-Based Capital
An insurance enterprise’s state of domicile imposes minimum risk-based capital requirements that were developed by the NAIC. The formulas for determining the amount of risk-based capital specify various weighting factors that are applied to financial balances or various levels of activity based on the perceived degree of risk. Regulatory
Statutory Financial Statements for the year ended December 31, 2023
ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
compliance is determined by a ratio of an enterprise’s regulatory total adjusted capital to its authorized control level risk-based capital, as defined by the NAIC. Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. This ratio for the Company significantly exceeds required minimum thresholds as of December 31, 2023 and 2022.
(16) Direct Premiums Written by Third-Party Administrators
The Company has direct premiums written by third-party administrators (TPAs). The types of business written by the TPAs include life, accidental death and dismemberment, medical, disability, excess risk, and LTC. The authority granted to the TPAs includes claims payment, claims adjustment, underwriting, binding authority, and premium collection. Total premiums written by TPAs were $3,686, $2,268, and $2,008 for 2023, 2022, and 2021, respectively. For the years ended December 31, 2023, 2022, and 2021, there were no individual TPAs that wrote premiums that equaled at least 5% of the capital and surplus of the Company.
(17) Reconciliation to the Annual Statement
The Company is required to file an Annual Statement with the Department. As of December 31, 2023 and 2022, there is no difference in admitted assets or liabilities between this report and the Annual Statement. As of December 31, 2023, 2022, and 2021, there is no difference in capital and surplus or net income between this report and the Annual Statement.
(18) Commitments and Contingencies
The Company may become subject to claims and lawsuits that arise in the ordinary course of business.
The Company is contingently liable for possible future assessments under regulatory requirements pertaining to insolvencies and impairments of unaffiliated insurance companies. Provision has been made for assessments currently received and assessments anticipated for known insolvencies.
The financial services industry, variable and fixed annuities, life insurance, distribution companies, and broker-dealers, is subject to close scrutiny by regulators, legislators, and the media.
Federal and state regulators, such as state insurance departments, state securities departments, the SEC, the Financial Industry Regulatory Authority, the Internal Revenue Service, and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning various selling practices, including suitability reviews, product exchanges, sales to seniors, and compliance with, among other things, insurance and securities law. The Company is and may become subject to ongoing market conduct examinations and investigations by regulators, which will or may result in fines and/or otherwise have a material adverse effect on the Company.
It can be expected that annuity and life product designs, management, and sales practices will be an ongoing source of regulatory scrutiny and enforcement actions, litigation, and rulemaking.
These matters could result in legal precedents and new industry-wide legislation, rules, and regulations that could significantly affect the financial services industry, including life insurance and annuity companies. It is unclear at this time whether any such litigation or regulatory actions will have a material adverse effect on the Company in the future.
(19) Subsequent Events
The Company has evaluated subsequent events through April 8, 2024, which is the date the Statutory Financial Statements were available to be issued. No material subsequent events have occurred since December 31, 2023 that require adjustment to the Statutory Financial Statements.
In March 2024, the Company received a capital contribution of $30,000 from Allianz Life.
Statutory Financial Statements for the year ended December 31, 2023